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FOREWORD BY THE CHAIRMAN 
 
This is not so much a report as a reality check and you only have to read the 
four or five pages detailing some case histories of unfortunates who dabbled 
in supposedly “harmless” cannabis and the consequences for themselves and 
their families to see what I mean.     
 
The title of the Report belies the serious nature of the subject.   There is no 
room for manoeuvre here, no room for a so called liberal outlook as often 
espoused by those who aim to dismiss the effects of cannabis and certainly 
no room for those who profit from peddling it to our vulnerable and 
impressionable young people.   
 
There has been much recent justified concern and indeed outrage at the 
preying on young people by sexual predators but do not be under any 
illusion: cannabis can be and in many cases is also a serious threat to our 
young people.   
The report clearly shows a link between the use of cannabis and the onset of 
mental illness in young people at a time in their lives when they are already 
potentially at risk from the onset of psychological problems.  Unborn 
children of young women who believe that cannabis is harmless are also 
very much at risk according to the latest research.  When you accept that 
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mental illness is managed rather than cured you can see the appalling vista 
induced by indulgence in cannabis with the consequent increased 
vulnerability to schizophrenia, depression and bipolar disorder.  The 
Members of the Joint Committee are convinced that the only attitude to 
cannabis should be – “noli tangere” or do not touch as the Romans used to 
say and that there should be no movement towards the liberalisation of the 
legal sanctions which attach to the possession of, use and dealing in this 
truly noxious weed.  Finally the Joint Committee wish to see the full rigours 
of the law applied to  those who benefit financially from trading in cannabis.   
                                                              Cecilia Keaveney T.D. 
                                                               Chairman 
  July 2006 
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  Recommendations of the Joint Committee 
 
As a first principle the Joint Committee regard cannabis as being as socially 
unacceptable as other harder drugs such as cocaine and heroin and those 
who profit from it should be pursued with the full rigour of the law. 
 
1. Given that there are reliably estimated to be some 300,000 users of 
cannabis in the state and the stated consequences for their mental and 
physical health the Joint Committee strongly recommends that a 
national strategy be drawn up with the aim of reversing the exponential 
rise in cannabis use over the past decade.  Particular emphasis must be 
paid to young women of childbearing age and their offspring and to 
young people in general given their vulnerability to mental health 
problems.  There is now compelling evidence that cannabis alone can 
result in later development of psychotic illness.   
2. The Joint Committee would like to see support for further 
neurobiological and clinical research to examine the long term 
cognitive impairment effects associated with heavy cannabis use, 
particularly those impairments relating to heavy use in adolescence and 
to prenatal exposure to cannabis.   
3. The Joint Committee wishes to draw attention to the physical effects of 
cannabis use and wishes to point out that the health risks are greater 
than those for conventional tobacco (more carcinogens, higher tar 
content).   
4. Given that the cannabis trade is worth more than €375 million and is the 
largest component of the vile drugs trade the Joint Committee urges that 
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greater resources be devoted to the criminal side and that there be a 
more pro-active pursuit of those who gain from it financially as is the 
case with the Class A drugs.   
5. Awareness of the risks of cannabis use as portrayed in this report needs 
to be raised through public information campaigns focused particularly 
on young people and their parents and we need to understand that 
cannabis is primarily a health issue.  
6. The Joint Committee recommends the adoption of prevention strategies 
where primary prevention attempts to reduce the number of new cases 
of cannabis use, where secondary prevention seeks to lower the rate of 
problem cannabis use and where tertiary prevention seeks to decrease 
the amount of disability associated with problem cannabis use.   
7.  The Joint Committee wish to see integrated treatment programmes for 
those with concurrent mental illness and substance abuse as individuals 
experiencing these disorders together face particular difficulty receiving 
diagnostic and treatment services although separately these disorders 
are treatable.    
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x Executive Summary 
 
x Cannabis use is seen across the socio-economic spectrum and it is 
by far the most common illicit drug of dependence in English-
speaking countries, including Ireland.   
 
x Many people who use cannabis are unaware of the physical, 
psychological and social risks associated with its use. 
 
x Both the use of and dealing in cannabis are criminal offences in 
Ireland. 
 
x The cannabis market in Ireland is worth about ʫ375million 
annually, this being more than the combined market for cocaine, 
heroin, ecstasy and amphetamines.   
 
x Cannabis use by Irish people as they enter early adulthood is a 
relatively new phenomenon. Those who grew up in 1960s, 1970s 
and 1980s in Ireland, were much less likely to experiment with 
cannabis than those who passed through their teens in the past 
decade.   
 
x It is estimated that there are in the region of 28,300 people in 
Ireland who are cannabis dependent.   
 
x People who develop cannabis problems are heterogeneous. They do 
not fit neatly into stereotypes. There are many routes into cannabis 
dependence. Similarly, there are many routes away from 
problematic cannabis use. 
 
x Irish teenagers are much more likely to use cannabis than their 
European counterparts and about 5000 (9%) of 16 year old school 
children in Ireland report using cannabis at least 3 times per 
month.    
 
x Cannabis plays a part as a stepping stone to more serious drug 
use.  In other words, it is rare for somebody to progress to heroin 
use or cocaine use without first having tried cannabis. However, 
most cannabis users never progress to using these other 
substances. 
 
x The vast majority of Irish people (69%) disapprove of people 
smoking cannabis occasionally.   
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x Even if the cannabis law was liberalised, it is likely that under 18’s 
will still need to be treated differently and their use accounts for a 
substantial proportion of the cannabis use that occurs in Ireland.  
 
x There is four times as much tar in a cannabis joint compared to a 
regular cigarette.  Cannabis smokers experience the same health 
problems as tobacco smokers, including bronchitis, emphysema, 
and lung cancer. 
 
x Peak incidence of cannabis use coincides with the time of 
maximum risk of developing serious mental health problems i.e. 
late teens and early adulthood.   
 
x Adolescent onset cannabis use leads to a four fold increase in the 
risk of developing schizophrenia.  
 
x Early onset cannabis use increases the risk of subsequently 
attempting suicide and those who started using cannabis before 
age 17 had a lower percentage of cortical grey matter compared to 
those who started later in life.   
 
x Third level students demonstrate particularly high rates of 
cannabis use. It seems likely that cannabis is a factor contributing 
to poor attainment and drop out by a sub-section of Irish 
Students.  
 
x Widespread drunkenness and Ireland’s tolerant attitude to alcohol 
intoxication provides cannabis users with a lot of ‘camouflage’.   
 
x Cannabis contributes to road traffic accidents, these being a major 
cause of mortality among young adults. 
 
x What a parent thinks to be alcohol intoxication in their teenage 
children may in fact be alcohol plus cannabis, or cannabis alone.  
Parents probably need as much education, if not more, than their 
children about cannabis. Education which has an exclusive focus 
on children will have a limited impact. 
 
x Heavy cannabis use among young females has begun to equal that 
of young males. This will pose distinct problems in pregnant female 
users with the potential for the emergence of a foetal cannabis 
syndrome as there is growing scientific evidence that cannabis use 
during pregnancy caries a risk of persistent neurocognitive 
changes in the newborn infants and neurobehavioural changes 
that emerge in childhood. 
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x Despite higher prevalence of cannabis use in the Dublin region, 
people from outside Dublin are much more likely to access 
treatment.  This indicates a reluctance or inability of cannabis 
users in Dublin to access treatment. The uneven and insufficient 
treatment provision for cannabis dependence across Ireland is 
something which must be addressed.   
 
x Individuals who enter treatment for cannabis abuse frequently cite 
the upset caused to the family and loved ones as the main reason 
for treatment seeking.   
 
x The aims of specialist services for problem cannabis use include 
harm reduction; abstinence and relapse prevention. 
 
x Evidence based treatment approaches for cannabis dependence 
include cognitive therapy and motivational interviewing. Family 
therapy has an important role in the treatment of adolescents. 
 
x In view of the strong association between cannabis use and mental 
illness and the fact that mental health professionals have the 
required skills to provide evidence based treatment for cannabis 
addiction, the logical location for provision of treatment is within 
mental health services. 
 
x There has never been a cannabis awareness campaign in Ireland. 
Education regarding cannabis is required across society and 
should not be exclusively focused on teenagers or schools. Indeed, 
teenagers are probably better informed about the risks and 
consequences of cannabis use than are their parents.  
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2. General Facts 
 
2.1 What is cannabis? 
Cannabis sativa and cannabis indica are members of the nettle family 
that have grown wild throughout the world for centuries. Both plants 
have been used for a variety of purposes including in the manufacture of 
hemp to make rope and textiles, as a medicinal herb and as the popular 
recreational drug - cannabis or marijuana, terms that are often used 
interchangeably.  The plant is used as: 
 The resin - a brown/black lump, known as bhang, ganja, hashish, 
etc;  
 
 The dried leaves - known as grass, marijuana, spliff, weed etc.  
Skunk is a new, stronger type of cannabis. There are around 100 
varieties of this and it is named after the pungent smell it gives off during 
growing. It is normally homegrown, either under grow lights or in a 
greenhouse, often using hydroponic (growing in nutrient rich liquids 
rather than soil) techniques. 
Both traditional cannabis and skunk come in a wide variety of strengths, 
so it is usually not possible to judge exactly what is being used in any 
one particular session. 
 
There has been growing concerns regarding cannabis potency. It is still 
unknown whether those who smoke higher potency cannabis have 
higher blood levels of THC1 or whether they titrate the dose according to 
the subjective and relatively immediate pharmacological effects. The 
relationship between potency, dose and consequent problems is still 
poorly understood. An increasing body of work has noted the association 
between the use of cannabis and the development of mental health 
problems such as psychosis, depression and schizophrenia, especially in 
those with pre-existing vulnerability. Here, however, exposure to the drug 
over time is likely to be the most important factor rather than potency of 
cannabis consumed in any one individual session of use (King et al, 
2005). 
 
 
                                                 
1 THC - tetrahydrocannabinol, the most psychoactive agent extracted from the cannabis 
plant 
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2.2 How is it cannabis used? 
Most commonly, the resin or the dried leaves are mixed with tobacco and 
smoked as a spliff or joint. The smoke is inhaled strongly and held in the 
lungs for a number of seconds. It can also be smoked in a pipe or 
collected in a container before inhaling it.   It can be brewed as tea or 
baked in cakes, and ingested. 
More than half of its psychologically active chemical ingredient, 1, 9-
tetrahydrocannabinol (9-THC), is absorbed into the blood when smoked. 
9-THC tends to build up in fatty tissues throughout the body and so 
takes a long time to be excreted in the urine. As a result cannabis can be 
detected in urine up to 56 days after it has last been used. 
 
 
2.3 What are the risks of cannabis use? 
 
There appears to be a poor general understanding of the risks of 
cannabis use. In a recent Swiss study neither younger (12-15 year old) 
adolescents, older (16-19 year old) adolescents, parents of teenagers and 
professionals working with young people, had any consensual vision of 
the risks of cannabis use or the definition of misuse. In the area of the 
prevention of cannabis use/misuse, while parents focused on the 
potential role of professionals and the media, thus minimizing their own 
educational and preventive role, professionals stressed the importance of 
parental responsibility for control and education. So that in reality 
parents were leaving it up to professionals and professionals working 
with young people were leaving education and awareness-raising to 
parents. This suggests an urgent need for information and clarification of 
the issues linked with cannabis use and misuse directed at parents, 
professionals and young people (Menghrajani et al, 2005).  
 
 
Case History: 
 
Seán was a rather shy 14 year old who was introduced to cannabis by 
some school friends.  He found that smoking helped him to relax, and over 
time began to rely on cannabis to help him feel part of the gang.  His 
parents were tolerant of cannabis use being of the view that this was a 
harmless recreational habit. After passing his Junior Cert, Seán’s parents 
began to notice that he had become progressively more withdrawn 
culminating with his revealing a wide range of suspicions to his parents 
about his classmates, teachers and strangers on the street. A referral to a 
psychiatrist followed.  
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2.4 Is cannabis addictive? 
 
Cannabis has some of the features of addictive drugs such as: tolerance 
– having to take more and more over time to get the same effect. There is 
growing evidence that regular cannabis users experience withdrawal 
symptoms when they stop using (Vandrey et al, 2005). 
 
2.5 How easy is it to become dependent on cannabis? 
 
The risk of becoming cannabis dependent within 24 months after first 
use of cannabis was assessed using the information from the National 
Household Survey on Drug Abuse conducted during 2000-2001, with a 
representative sample of 114,241 residents of the USA aged 12 and older. 
A total of 3,352 respondents were found to have used cannabis for the 
first time within a span of up to 24 months prior to assessment. An 
estimated 3.9% of these recent-onset users developed a cannabis 
dependence syndrome during the interval since first use (median interval 
duration ~12 months). Excess risk of cannabis dependence was found for 
those with cannabis onset before late-adolescence, those with family 
income less than US$ 20,000, and those who had used three or more 
drugs before the first use of cannabis (i.e., tobacco, alcohol, and other 
drugs). This study's focus on recent-onset users more closely 
approximates prospective and longitudinal research on the incidence 
(risk) of becoming cannabis dependent soon after onset of cannabis use, 
removing the influence of users with long-sustained or persistent 
cannabis dependence developed years ago (Chen et al, 2005).  
 
 
2.6 What is the extent of the cannabis problem? 
 
Cannabis is by far the most common illicit drug of dependence in 
English-speaking countries (Hall et al, 1999). The Australian National 
Survey of Mental Health and Well-being reported that among those using 
cannabis on at least five occasions in the previous year, 23.3% met ICD-
102 criteria for a current cannabis use disorder (Hall et al, 1998). These 
Australian rates of current cannabis disorder are even higher than the 
U.S. National Co-morbidity Study, which found that 9.2% of those who 
reported any lifetime use of cannabis developed dependence as measured 
by DSM-III-R criteria3 (Anthony et al, 1994). 
                                                 
2 ICD-10.  The International Classification of Diseases, Version 10.  Geneva: WHO, 
1994. 
3 DSM -111-R. The Diagnostic and Statistical Manual of Mental Disorders, third edition 
(revised).  Washington:  American Psychiatric Association, 1987. 
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Along with the growing recognition of the range of potential cannabis-
related harms (Kalant et al, 1999), there is an increasing demand for 
treatment.  
 
2.7 What factors influence dependence and outcome? 
 
Social influences are important in terms of prevention and interventions 
(Chabrol et al, 2005).   The number of one's peers using cannabis is a 
risk factor whereas the number of peers opposed to cannabis use is a 
protective factor. 
 
Education can affect the lives of adolescents by reinforcing healthy 
choices and promoting a healthy lifestyle. However, difficulties 
experienced in the school and family environments may interfere with 
these goals. This may be particularly true for those youth already 
participating in health-compromising behaviors such as drug use. Of 
course, patterns of drug use take many forms, and some are more 
serious than others. Youth using cannabis at more intensive levels have 
often been overlooked in the literature. Butters (2005) addressed this gap 
by examining the effects of individual and cumulative school and family 
factors on not only the probability of any cannabis use but also the 
progression to problem use among almost 2000 Ontario students. The 
results suggested that disrupted family structure increased the likelihood 
of cannabis use in general. However, patterns of problem use were 
displayed among youth experiencing problems in school and poor family 
relationships. As anticipated, adolescents experiencing multiple school 
and family factors were also significantly more likely to engage in 
cannabis use, and in its more serious form, when controlling for other 
demographic predictors. This has implications for health promotion 
initiatives in schools. 
 
Data from 552 adolescents (aged 12-18; 82% male) with cannabis abuse 
or dependence, who participated in outpatient treatment, indicated that 
environmental factors of family conflict, family cohesion, and social 
support indirectly predicted substance use and substance-related 
problems as mediated by recovery environment and social risk. These 
results support the idea of targeting environmental factors during 
treatment as a way of improving outcomes for adolescents with cannabis 
disorders (Godley et al, 2005).  
 
2.8 What are the common problems associated with cannabis use? 
 
Many – perhaps most – people who use cannabis have no complaints. 
Most are unaware of the risks associated with use but for some, it can 
become a problem. A US organization  marijuanaanonymous.org defines 
the problems of cannabis as: “if marijuana controls our lives and our 
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thinking, and if our desires center around marijuana - scoring it, dealing 
it, and finding ways to stay high so that they lose interest in all else.” 
Their website carries the following questionnaire – which could equally 
well apply to alcohol use or any other drug. 
 
“If you answer ‘Yes’ to any of the questions, you may have a problem. 
 
1. Has smoking pot stopped being fun? 
2. Do you ever get high alone? 
3. Is it hard for you to imagine a life without marijuana? 
4. Do you find that your friends are determined by your marijuana use? 
5. Do you smoke marijuana to avoid dealing with your problems? 
6. Do you smoke pot to cope with your feelings? 
7. Does your marijuana use let you live in a privately defined world? 
8. Have you ever failed to keep promises you made about cutting down or 
controlling your dope smoking? 
9. Has marijuana caused problems with memory, concentration, or 
motivation? 
10. When your stash is nearly empty, do you feel anxious or worried 
about how to get more? 
11. Do you plan your life around your marijuana use? 
12. Have friends or relatives ever complained that your pot smoking is 
damaging your relationship with them?” 
 
2.9 What about reducing cannabis use? 
 
The Home Office in Britain recently published a guide on how to cut 
down and stop cannabis use (www.homeoffice.gov.uk/materials/kc-
stop.pdf).  Once the decision is made to give up cannabis, it may be no 
more difficult than giving up cigarettes.  It suggests a range of things a 
person can do to successfully stop using, including: 
x Drawing up a list of reasons for wanting to change 
x Planning how the person will change 
x Thinking about coping with withdrawal symptoms, and 
x Having a back-up plan. 
 
2.10 What do-it-yourself strategies are there for giving up cannabis? 
 
Many people will be able to stop on their own. The website 
www.talktofrank.com is helpful for someone wishing to give up cannabis 
on a do it yourself basis using the information on this website.  There are 
also on-line support groups available e.g.www.marijuanaanonymous.org. 
or www.connexions.gov.uk that is a UK-based website for 13-19 year 
olds, which offers support and can put individuals in touch with a 
practitioner or personal adviser.  A person who wants to give up 
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cannabis use but who feels unable to do so may seek help from their GP 
and they can also be referred on to more specialist services.  
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3. Epidemiology 
 
3.1 The Journey from Experimentation to Dependence 
 
Some people will decide to experiment with drugs, most typically during 
their teenage years or in early adulthood. Many of those who experiment 
with a substance will quickly decide to stop, their curiosity being 
satisfied.  However, a proportion of those who experiment will continue to 
use infrequently over the coming months and years.  Some of those who 
continue to use a substance will become quite regular users.  Of those 
who become regular users, a subset will become problematic or 
dependent users of the substance. This potential progression from first 
experimentation to dependence is seen in all drugs, including cigarettes, 
alcohol, heroin and cannabis. 
 
With regard to cannabis in Ireland, a number of epidemiological studies 
provide insights into the proportion of people who experiment and the 
proportion that move from experimentation to more problematic patterns 
of regular use.   
 
3.2 Young Children 
 
There has been very little research regarding the use of cannabis by 
young children. The Health Behaviour In School-age Children (HBSC) 
study found that 1-2% of Irish 10 – 12 year olds reported past cannabis 
use (Kelleher et al, 2003). 
 
A study was recently conducted in Glasgow examining 10 – 12 year olds 
(McIntosh et al 2004).  This study found that 10% of children in this age 
range had been offered cannabis.  About a quarter had been in the 
company of others who were using cannabis. While the study was not 
conducted in Ireland, there is no reason to believe that the situation in 
large urban centres in Ireland would be any different, given the fact that 
the profile of cannabis use in Scottish teenagers and Scottish adults is 
quite similar to that seen in urban settings in Ireland. 
 
3.3 Teenagers.   
 
3.3.1 Frequency of Experimentation & Regular Use 
There is substantial epidemiological evidence regarding the extent of 
cannabis use among Irish teenagers.  This data is made more interesting 
by the fact that it has been collected over the past decade, making 
evaluation of temporal trends possible.  The European School Survey 
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Project on Alcohol and Drugs (ESPAD) study was conducted in 1995, 
1999 and most recently in 2003 (Hibell et al, 1996; Hibell et al, 2000; 
Hibell et al, 2004).  These studies looked at 16-year-old school children 
in 30 countries across Europe.  Students were asked about their past 
use of and attitudes towards a range of legal and illegal substances, 
including cannabis.  The ESPAD study indicates that Irish teenagers are 
much more likely to use cannabis than their European counterparts (See 
figures 1, 2 & 3).  In the most recent ESPAD study, it emerged that 38% 
of Irish 16 year olds have used cannabis at least once, with 6% reporting 
cannabis use on at least 40 occasions.  Thirty per cent of Irish 16 year 
olds say that they have used cannabis in the last year with 16% 
reporting use in the last month. Nine per cent (i.e. 5,000) of 16 year old 
school children report using cannabis at least 3 times in the last month 
(Hibell et al, 2004).  While males demonstrated higher rates of self 
reported cannabis use in the earlier ESPAD studies, the reported rates of 
occasional and heavy use of cannabis by 16 year old school girls in 
Ireland is equal to that demonstrated by the 16 year old boys in the 2003 
study.  The HBSC study found similar rates of self reported cannabis use 
(Kelleher et al, 2003). 
 
Figure 1. Cannabis use in the past year reported by 16 year old 
school children in the ESPAD studies 
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Figure 2. ESPAD - 16 year old schoolchildren - Use of cannabis in 
the past month 
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Figure 3. ESPAD - 16 year old schoolchildren across Europe and the 
USA- Heavy cannabis users (3+ times in past month) 
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3.3.2 Context of First Use & Availability 
Cannabis was the first drug used in 97% of cases where illicit drug use 
was reported (Hibell et al, 2004).  Generally, this first introduction to 
cannabis occurred in a social context with friends or an older sibling. 
Only 5% of those who had used cannabis reported that their first use 
was provided by anyone other than a friend.  Twenty per cent of the 
schoolchildren who had used cannabis did so before their 14th birthday.  
Unfortunately, Irish teenagers perceive cannabis to be more easily 
available than any of their European counterparts (See Figure 4).  Thirty 
per cent indicated that cannabis was easily available in their school, this 
being double the European average for that particular setting.  In 
general, 60% of Irish 16 year olds reported that cannabis was very or 
fairly easy to obtain.  Again, the European average response to this 
particular question was just 35%.   
 
Figure 4. ESPAD - 16 year old schoolchildren’s' perception that 
cannabis is very or fairly available 
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3.3.3 Perceived danger in Cannabis Use 
Students were also asked whether or not they perceived cannabis use to 
be of great risk to their health.  Students differentiated between cannabis 
use once or twice only versus regular use, as 54% perceived regular use 
to be a great risk.  Only 15% perceived use on one or two occasions to be 
of great risk.   They perceived substantially less risk than their European 
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counterparts, with the corresponding average figures across Europe 
being 70% and 32% for these two questions.   
 
3.3.4 Disapproval of Cannabis Use 
The earlier 1999 ESPAD study had included an additional question 
regarding the disapproval of substance use.  The 16 year olds were asked 
whether they would disapprove of someone using cannabis on one or two 
occasions.  Fifty-seven per cent of Irish students reported disapproval of 
cannabis experimentation. In most other European countries many more 
teenagers disapproved of this behaviour, with the average being 69%.  
Across Europe there tends to be an inverse relationship between 
disapproval of cannabis use and the actual rates of regular cannabis use.  
In other words countries with high rates of disapproval of use 
demonstrated low rates of actual use.  Correspondingly, countries such 
as Ireland, which had relatively low rates of disapproval of use had the 
highest rates of actual regular use. 
 
3.4 Third Level Students. 
 
The College Lifestyle and Attitudinal National (CLAN) Study was 
conducted in 2002 and 2003 among third level students in Ireland (Hope 
et al, 2005).  Their average age was 21 years at the time of interview.  
Thirty seven percent reported cannabis use in the past year. Fifteen 
percent reported cannabis use at least 10 times in the past year.  Twenty 
percent reported cannabis use in the past month.  Regular cannabis use 
(at least 10 times in the past month) was reported by 9% of males and 
3% of females.  These rates of use in the past year, past month and 
heavy use are marginally greater than those seen in the 2003 ESPAD 
study of Irish 16 year olds.  Although there is a substantial gender 
difference seen among the 21 year olds in this CLAN study, it seems that 
this reflects the patterns of cannabis use which would have been seen 
among Irish 16 year olds in the mid to late 1990’s, where heavy cannabis 
use was much more common in young males (Hibell et al, 1996; Hibell et 
al, 2000).  It is likely that the findings from the ESPAD study 2003, 
which showed rates of heavy cannabis use among young girls equaling 
that of young boys, may well persist into early adulthood (Hibell et al, 
2004).  Consequently, we predict that if the CLAN study is repeated in 
2008, by the time this cohort reaches 21 years, there will be as many 
females as males reporting heavy cannabis use. This will result in a rise 
in the prevalence of heavy cannabis use at the population level. 
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3.5 Adults 
 
3.5.1 NACD Study of Drug Prevalence in Ireland 
The National Advisory Committee on Drugs conducted a large population 
study on drug use in 2002.  This involved face to face interviews with 
almost 5000 people aged between 15 years and 65 years.  It is worth 
noting that the methodology in this study is different than in the 
previously mentioned studies (ESPAD, HBSC and CLAN), where 
anonymous questionnaires were completed by study participants.  The 
results specific to cannabis were recently published (NACD, 2005a).  Of 
the 4,900 people interviewed, just over 17% reported some past use of 
cannabis, with males being almost twice as likely to report such use.  
Lifetime exposure to cannabis was substantially higher in younger adults 
aged 15 – 34 years (24% compared to adults over 35 years 11%).  This 
mirrors findings from earlier research and confirms the fact that 
cannabis use by Irish people as they enter early adulthood is a relatively 
new phenomenon (Bryan et al, 2000). Those who grew up in 1960s, 
1970s and 1980s in Ireland, were much less likely to experiment with 
cannabis than the cohort who passed through their teens in the past 
decade. 
 
The last year prevalence was 5% in the overall population and the last 
month prevalence was 2.6%.  The rates of recent use seen in young 
adults less than 35 years old were about 4-5 times those seen in older 
adults.  Among those who reported use in the past month, 40% had only 
used on a couple of occasions while 22% were using on an almost daily 
basis.  This indicates that about 1% of young people aged 15 years – 34 
years in Ireland report using cannabis on an almost daily basis.   
 
 
3.5.2 Higher rates of use in College Students and Graduates 
In an examination of the relationship between cannabis and work status, 
students were much more likely to smoke cannabis in the last year or 
the last month, when compared to those in work and those who were 
unemployed.  Linked to this, there is a trend seen across the population 
for an escalation in rates of both past and recent cannabis use when 
individuals were ranked by educational level attained, with the highest 
rates of use seen in those who had attained a third level qualification.   
 
The relationship between cannabis use and the socio-economic group 
was complex.  Use tended to peak in the middle socio- economic groups.  
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3.5.3 Patterns of use among recent cannabis users 
The people who reported using cannabis in the last month were asked 
what type of cannabis they had used.  Seventy-nine per cent reported 
use of hash (or cannabis resin) while 26% reported some use of grass or 
weed.  The vast majority of cannabis users consumed it by smoking it in 
a joint.  Seven per cent reported use of a pipe while 6% reported use of a 
bong.  Just over 3% reported eating some cannabis in the past month.   
 
People who had consumed cannabis in the last month were also asked 
where they had obtained the cannabis on the last occasion of use.  
Among these individuals, 79% said that cannabis was very easy or fairly 
easy to obtain.  The vast majority (70%) reported that they bought it from 
or were given it by friends or family. Only 16% indicated that they had 
bought it from a contact that was not known personally to them.  Most 
people (57%) reported that they were in the house of a friend when they 
last used cannabis. One fifth were in a disco, bar or club.  One per cent 
ordered by phone and 7% went to the house of a dealer.   
 
 
3.5.4 Regular Users 
It emerged that 73% of the people who tried cannabis never developed a 
pattern of regular use. On the other hand, 27% of users reported that 
they had a pattern of regular use either currently or at sometime in the 
past.  Fifty-eight per cent of these had stopped their cannabis use, 12% 
tried to stop but failed and 30% of these regular users had never tried to 
stop.   
 
Past regular cannabis users were given a variety of possible factors to 
choose from regarding their reason(s) for stopping cannabis use.  The 
most commonly cited reason (43%) was that they “did not want to take it 
anymore”.  One in four reported that it was no longer part of their social 
life, while 23% reported that they did not enjoy the after effects.  Twenty 
per cent developed health concerns and 11% indicated that they were 
persuaded to curtail their use following pressure from friends and family.  
Cost was a factor of just 8% of individuals, while impact on job, family or 
friends was cited also by 8%.  Twenty percent of women who had been 
regular smokers stopped as a result of pregnancy.  Unfortunately 
interviewees were not asked whether or not the legality of cannabis use 
or any criminal justice concerns or consequences, contributed to their 
decision to discontinue regular use.   
 
 
3.5.5 Geographical variation 
The NACD study looked at prevalence of cannabis use in the different 
health board regions of Ireland. The last year prevalence of cannabis use 
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was higher in the region around Dublin, ranging from 10 to 12.6 %. In 
the health board areas outside of Dublin, the corresponding figure varied 
from 10.6% in the North East to a low of 3.9% in the North West. An 
earlier nationwide population survey had found a rates of lifetime 
cannabis use in rural settings to be two-thirds those seen in urban 
settings (Bryan et al, 2000). 
 
 
3.6 Cannabis Dependence. 
 
Contrary to popular opinion, people can become dependent upon 
cannabis (Vandrey et al, 2005).  Unfortunately there has been no large-
scale Irish study to measure cannabis dependence.  Internationally, it 
has been observed that about 10% of those using cannabis are 
dependent upon it (Kandel et al, 1997).  Consequently based upon the 
various epidemiological studies outlined above, which indicate that about 
30% of 15 – 24 year olds have used cannabis in the past year (192,500 
people), we estimate that 3% of people in this age group (19,250) are 
dependent upon cannabis, based on Irish population reports from the 
2002 census.  Cannabis use is lower in older age ranges but it seems 
likely that about 1% of people aged between 26 years and 35 years 
(6,150) are dependent on cannabis, based on an estimate of about 10% 
of those using cannabis in the last year.  Based on the NACD Study, 
which found that just 2% of people over the age of 35 years had used 
cannabis in the past year, we estimate that about 0.2% of people aged 
between 35 years and 64 years are cannabis dependent (2,900).  Based 
on these figures, we estimate that the population of people in Ireland who 
are cannabis dependent to be in the region of 28,300.  It is these 
individuals who are most likely to encounter the various physical, 
psychological and social harms outlined elsewhere in this report.   
 
 
3.7 Factors Associated With Increased And Decreased Risk Of 
Cannabis Initiation And Cannabis Dependence. 
 
Research indicates that some individuals are more likely to develop 
problematic patterns of cannabis use.  Risk and protective factors have 
been identified at the individual level, family level and the wider 
community or societal level. It is important to note that people who have 
no individual, family or community risk factors may still develop 
cannabis problems. Similarly, many individuals who appear to have 
almost every individual and family risk factor will not develop 
problematic cannabis use.  
 
 
 
 34
3.7.1 Characteristics of the Individual  
Individual risk factors include a history of conduct disorder and poor 
attachment to parents and community.  Young people with lower IQ and 
difficulties in the area of social and communication skills are also more 
vulnerable to drifting into patterns of cannabis abuse.  Children who 
smoke cigarettes and begin drinking alcohol at an early age are more 
likely to progress to cannabis use. Early onset of cannabis use is 
associated with greater risk of dependence in adulthood. Children who 
demonstrate a characteristic of temperament known as sensation 
seeking are also more at risk (Gilvarry, 1999). The NACD prevalence and 
CLAN studies outlined above indicate that third level students are more 
likely to use cannabis than same aged groups of the general population 
(NACD, 2005a). 
 
 
3.7.1.1 ‘Peer Pressure’ and Peer Influence 
Peer pressure is regularly mentioned as a factor causing cannabis use.  
However, the most frequently cited reason by teenagers for first 
experimenting with cannabis is curiosity. Peer pressure or “not wanting 
to feel left out” is cited by less than 10% (Hibell et al, 2003). It is 
important to bear in mind that peer influence can be both positive and 
negative. Whether or not this influence is positive or negative will depend 
on the attitude of ones peers.  As mentioned above, the majority of Irish 
16 year olds surveyed in 1999 actually disapproved of cannabis use 
(Hibell et al, 2000).  Consequently teenagers who socialise with peers 
who disapprove of cannabis use are likely to be kept “on the straight and 
narrow” and avoid cannabis use due to the peer pressure.  However 
teenagers who drift into the company of peers who approve of cannabis 
use are subsequently more likely to develop patterns of use themselves.  
 
 
3.7.1.2 Complex impact of Self-Esteem 
Self-esteem is also frequently cited as a risk factor for the development 
for cannabis and other drug problems, particularly during adolescence.  
Recent research indicates the complexity of the relationship between self-
esteem and drug use.  It appears to be the case that children with higher 
self-esteem are more likely to experiment with drugs such as cannabis 
than their counterparts with lower self-esteem (Ashton, 2004).  However, 
among those who do progress to experimentation and occasional 
cannabis use, it is those with lower self-esteem who may to be more at 
risk of progressing to patterns of problematic or dependent use.   
 
 
3.7.2 Family factors 
There are a number of family factors that have been identified as 
increasing and decreasing the risk of a young person developing 
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cannabis abuse (Gilvarry, 1999).  The risk factors include parental drug 
or alcohol abuse and a tolerant attitude to cannabis use and intoxication 
by parents.  Where children experience a style of parenting that is 
perceived to be critical and harsh, they are more likely to develop 
problematic patterns of cannabis use.  Where parenting involves poor 
supervision, a lack of clear rules or insufficient monitoring of these rules, 
the risk of teenagers abusing cannabis escalates (McIntosh et al, 2004).   
People who grow up in families where violence is commonplace seem 
more likely to develop patterns of cannabis use.   
 
Protective family factors include the existence of clear rules which are 
adequately monitored and enforced. Young people with a positive 
attachment to at least one parent are less likely to develop substance 
abuse problems.  
 
Case History 
 
Edward is fifteen and has been smoking cannabis most evenings for the 
past year. He has been taking ‘speed’ (amphetamine) with some friends at 
weekends. His mother is aware of his cannabis smoking and is very 
worried about it. They have been getting into lots of arguments about both 
his drug use and the fact that he stays out so late at night. His father 
thinks that Edward is treating the family home as ‘a hotel’ and they 
frequently end up shouting at one another. His father has said that he 
would ‘kick him out of the house’ if he ever used a drug. For this reason, 
his mother has agreed not to tell his father about the cannabis smoking. 
 
He has just completed his Junior Cert and has obtained seven honours. He 
is well liked by peers and teachers. He hopes to go to college after his 
Leaving Cert. He works in the local shop three evenings a week for pocket 
money. 
 
Everyone is getting very frustrated with the situation at home but Edward 
doesn’t see any substantial problem with his drug use. He thinks that 
alcohol is a much nastier substance than cannabis. He has seen the way 
his parents row with one another when they are drunk. He thinks his 
father is a hypocrite and stupid to be spending most of Saturday and 
Sunday lying in bed recovering from a hangover. 
 
Edward has been very close to his mother in the past and he hates the 
fact that she is upset and worried about his drug use. After their 
arguments, he feels very guilty. He usually then either goes to his room or 
goes out to his friends. When feeling down, he likes to smoke a joint in 
order to ‘switch off’. 
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3.7.3 Societal factors 
There a number of societal factors that may also be influence the gradual 
escalation of cannabis use seen in Ireland over the past number of 
decades.  Firstly, Ireland has an unusual attitude to intoxication by 
international standards.  Drunkenness is not just tolerated but actively 
sought after and even admired in many sectors of Irish society.  In 
contrast drunkenness is something to be ashamed off and apologised for 
in many European cultures, particularly those in the Mediterranean 
region. The majority of Irish men binge on any given drinking occasion 
(Ramstedt & Hope, 2005).  It is now the case that young people have a 
broader menu of intoxicants to choose from than was previously the case 
in Ireland.  Cannabis is readily available as indicated in the various 
studies of the general population and schoolchildren outlined above 
(Hibell et al, 2003; NACD, 2005).  Some young people are clearly 
choosing cannabis as an alternative intoxicant with or instead of alcohol.  
The high prevalence of intoxication in Irish social settings provides 
people who abuse drugs including cannabis with a lot of camouflage, 
making their own intoxicated state less noticeable and more socially 
acceptable.   
 
As a society, Ireland has enthusiastically embraced capitalism and 
consumerism over the last decade.  A cornerstone of consumerism, 
fuelled by relentless advertising, is the encouragement of the individual 
to indulge in the moment, to avoid postponing pleasure and to ignore 
long term negative consequences in favour of the short-term benefit of 
the product that is on offer.  Against this backdrop, it is not surprising 
that more young people are choosing to ignore the longer term risks that 
are associated with drug use and instead, they are choosing to seek out 
the pleasurable, but short-lived hedonic effects that are associated with 
drug use.   
 
The criminal justice response to cannabis is inevitably an influence over 
cannabis use. The extent of this influence is open to substantial debate.  
Those who argue for a liberalisation in the law suggest it has a minimal 
influence in reducing demand (Runciman, 1999; Wodak et al, 2002). 
Following the reclassification of cannabis from a class B to a class C 
drug, the Advisory Council on the Misuse of Drugs (2005) concluded that 
there was no increase in cannabis use in the UK population. Those who 
are enthusiastic regarding the criminalisation of cannabis argue that it 
has a substantial deterrent effect on use. This remains to be proven, and 
is discussed in more detail elsewhere in this report (see discussion on 
British Cannabis Policy, section 4.3).  Research examining the factors 
why young people who have access to cannabis and choose not to use it, 
would be helpful in this regard.  Similarly the influences of criminal 
justice issues in causing some young people who have experimented with 
cannabis to discontinue use are worth examining.   
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It is also important to note that the use of intoxicating substances across 
Europe varies greatly from culture to culture, despite substantial 
similarities in the criminal justice responses and indeed the regulation 
around these substances.  For example, with regard to alcohol, public 
order offences, drunkenness and alcohol abuse are commonplace in 
Ireland while countries with a more relaxed regulation demonstrate 
patterns of lesser use.  It does seem likely that the dominant influence on 
patterns of use of mood altering substances, such as alcohol and 
cannabis, relate much more to societal attitudes to use and abuse of 
these substances rather than simply the criminal justice response.   
 
 
3.8 Treatment Attendance 
 
The numbers of people seeking and obtaining addiction treatment for a 
drug problem where cannabis was either the primary drug or a 
secondary drug has more than doubled in Ireland from 1998 to 2002, 
rising from 1938 people to 4171 (DMRD, 2005).  Figure 5 outlines the 
number of attendances for primary cannabis abuse/dependence. 
Children are accounting for a growing proportion of these treatment 
contacts rising from less than one in four cases in the 1990s to one in 
three of those treated in 2003. 
 
 
 38
Figure 5. Numbers accessing addiction treatment for a primary 
cannabis problem, by age-group, 1998-2003. (Unpublished data from 
the National Drug Treatment Reporting System4) 
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The NACD Prevalence Study found higher rates of cannabis use in the 
greater Dublin area (Dublin, Kildare, Wicklow) compared to the southern 
counties of Cork, Kerry, Waterford, Tipperary South, Wexford, Carlow & 
Kilkenny (NACD, 2005b). The population of the greater Dublin area is 
about 40% greater than that in these combined southern counties 
(Census 2002). Consequently, one would anticipate that the greater 
Dublin region would account for a greater proportion of the national 
cannabis treatment attendances. However, it emerged that only 165 
people obtained treatment for cannabis abuse in the greater Dublin area 
during 2003. This compares to a figure of 860 people accessing cannabis 
treatment from these southern counties (unpublished data from the 
National Drug Treatment Reporting System). The numbers of people 
seeking and obtaining addiction treatment for a drug problem where 
cannabis was either the primary drug or a secondary drug has escalated 
substantially in Ireland during the period 1998 – 2002, rising from 1938 
people in 1998 to 4171 in 2002 (DMRD, 2005).  Despite the facts that the 
NACD Prevalence Study indicated higher rates of cannabis use in Dublin 
and that one quarter of the Irish population lives in Dublin, the Dublin 
region only accounted for 10% of the actual number of incident 
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treatment episodes for primary cannabis abuse in Ireland (DMRD, 2004).  
This indicates one of two possibilities.  The first of these is that cannabis 
users in Dublin do not perceive problems associated with cannabis to be 
of such a severity to cause them to seek treatment.  The second, and 
more likely possibility, relates to the fact that the treatment services in 
Dublin for addiction are currently focused primarily on managing opiate 
dependence. Consequently people who have cannabis problems are 
unlikely to seek treatment in these locations, possibly perceiving the 
service to be irrelevant to their particular needs.  The uneven and 
insufficient treatment provision for cannabis dependence across Ireland 
is something which must be addressed.  
 
 
 
Case History 
 
Alan played music with a group and smoked cannabis after playing gigs.  
His friends noticed his increased moodiness, unreliability and irritability 
eventually dropping him from the group. Alan dropped the occasional 
Ecstasy tablet and over time experimented with cocaine and heroin.  To 
fund his drug habit, he began engaging in some dealing.  He became 
alienated from his family of origin from whom he had stolen and he 
developed Hepatitis C. He attended his local drug treatment centre and 
was put on a Methadone Maintenance Programme.  He continues to smoke 
cannabis and spends most days lying on the sofa watching daytime TV. 
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4. Cannabis policy - Ireland & Abroad  
 
4.1 Introduction  
 
International laws governing substances strive to balance individual 
freedoms, individual’s risk to their own health and the potential for harm 
to the wider society from such substance use.  Illicit drugs tend to be 
classified on the basis of their harmfulness to individuals and society, 
deeming those in the higher classes e.g. cocaine or heroin because of 
their being most harmful and consequently also attracting more severe 
penalties and sanctions.  The social and legal status of cannabis cannot 
be determined solely by claims and counterclaims on health grounds.  
One of the key determinants of the legal status of cannabis is likely to be 
the social and moral attitudes to a range of psychoactive substances and 
the anxiety that some patterns of social behaviour are strongly linked to 
its use (Farrell & Ritson, 2001). 
 
Cannabis is the most widely trafficked drug globally. In Ireland, as in 
most other countries, there are more seizures of cannabis than of any 
other drug. Garda figures show a steady increase in the total number of 
cannabis-related offences in recent years and in 2005, cannabis-related 
seizures accounted for 57% of the total number of drug seizures. 
According to the Annual Report of An Garda Síochána (2005) cannabis-
related offences accounted for 54 per % of the total number of drug 
offences in which criminal proceedings commenced.   
 
4.2 Legal framework in Ireland  
 
In Ireland, the Misuse of Drugs Act, 1977, Section 3 makes it an offence 
for a person to have a controlled drug in his possession.  However a 
graded scale of penalties exists for cannabis relative to other drugs as is 
evidenced by the proscribed fines and sentences under the Act.  Section 
27 of the Act as amended by Section 6 of the Criminal Justice Act, 1984 
specifies that where the relevant controlled drug possessed by the 
individual is cannabis and when it can be proven to the satisfaction of 
the Court that this is for the individual's own use, the penalty should be 
a fine on the first offence up to a maximum of €380 on summary 
conviction and €634 on indictment. For a second offence, the maximum 
fines are €507 and €1269 on indictment and for a third offence and on 
summary conviction, the maximum fine is a 12-month prison sentence, a 
€1,269 fine or both.  The cultivation of cannabis plants is also an offence 
under the Act.  In contrast the possession of a drug other than cannabis 
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attracts a harsher maximum penalty, of 12 months’ imprisonment on 
summary conviction, a €1269 fine or both. For conviction on indictment 
of these drugs, the maximum sentence is seven years’ imprisonment, a 
discretionary fine or both (Connolly, 2004). 
 
4.3 British Cannabis policy 
 
The debate over cannabis law reform remains one of the most contested 
areas of international drug policy.  Many of the negative consequences 
related to cannabis have unfortunately been attributed to its legal status, 
rather than to any properties of the drug itself. The legal status of 
cannabis has come under increased debate in recent years in Ireland 
probably as a result of the decision in Britain in 2001 to examine their 
then current classification of cannabis.   
 
In 2000, The Police Foundation in Britain produced a report Drugs and 
the Law which recommended reclassification of cannabis on the basis 
that "by any of the main criteria of harm - mortality, morbidity, toxicity, 
addictiveness, and relationship with crime - it is less harmful to the 
individual and society than any of the other major illicit drugs, or than 
alcohol or tobacco" leading to a conclusion that the existing law on 
cannabis produced more harm than it prevented and that it lead to the 
criminalising of "large numbers of otherwise law-abiding, mainly young, 
people to the detriments of their futures". 
 
In 2002, the Advisory Council on the Misuse of Drugs (ACMD) concluded 
that the current classification of cannabis in Britain was 
disproportionate to its toxicity and to other substances that were then 
currently also similarly classified as Class B drugs e.g. amphetamines.  
They recommended that the existing law be relaxed and that cannabis be 
reclassified from Class B to Class C - a class that also includes 
performance enhancing steroids.   The reclassification was finally 
enacted in late January 2004.  The main pragmatic difference in this 
reclassification is that while supplying and trafficking Class C drugs 
remain criminal offences, possession of cannabis for personal use is no 
longer subject to arrest. 
 
There was considerable support for this reclassification on the basis that 
the available evidence suggested that cannabis was considerably less 
harmful than many of the drugs it was currently classed alongside in 
Class B. It was felt that young people in particular needed to be able to 
assess potential harms of illicit substances as accurately as possible and 
only an accurate classification would do this. A classification that was 
too high could lead it was felt, to young people disregarding not only 
cannabis warnings but also warnings about more serious drugs like 
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crack and heroin, according to a drugs information charity (Drugscope 
(2004) www.drugscope.org.uk).  
In March 2005 the then British Home Secretary Charles Clarke asked 
the ACMD to examine new evidence, particularly the link between 
cannabis and psychosis and to consider whether this changed their 
assessment of the drug's classification.  
In January 2006 it was announced that cannabis was to be retained as a 
Class C drug (ACMD, 2005).  The ACMD remained nevertheless of the 
view that cannabis is harmful and that its consumption could lead to a 
wide range of physical and psychological hazards.  It did not however 
recommend that the classification of cannabis products should be 
changed on the basis of the results of recent research into the effects on 
the development of mental illness.  Although cannabis was considered to 
be unquestionably harmful, in the view of the ACMD its harmfulness did 
not equate to that of other Class B substances either at the level of the 
individual or of society. 
 Two conclusions from the ACMD report are worth stating however: 
1. That cannabis is harmful and that its use can lead to a wide range of 
physical and psychological harms and hazards; that the mental health 
effects of cannabis are real and significant; that cannabis is potentially 
harmful with short-term risks to physical health; that a substantial 
research programme into the relationship between cannabis and mental 
health should be instituted; that the Government ought to seek to reduce 
the use of cannabis and that the cultivation, supply and possession of 
cannabis should remain illegal. 
2. That the level of classification is only one amongst the issues to be 
addressed and that priority needs to be given to proper enforcement of 
the law, to education and to campaigning against the use of cannabis. 
It has been felt that the debate about reclassification in Britain has 
actually helped to raise awareness of the dangers of cannabis but a 
major public health campaign to reinforce this message has been called 
for. "Cannabis is harmful but less so than Class B drugs and there is no 
evidence that a move back to B would reduce levels of use. Since 
reclassification there had been a small decrease in cannabis use 
particularly among young people and the police are better able to focus 
on tackling even more harmful drugs. There was some initial confusion 
following reclassification but the vast majority of people now realise that 
cannabis is illegal and not harmless" (Drugscope Press Release, January 
2006). 
The mental health charity Rethink has been critical of the relative lack of 
importance placed on the evolving evidence of a causal link between 
psychosis and cannabis use in the debate on cannabis classification, a 
focus on that "rather than fiddle with its legal status" being their 
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contention (www.rethink.org/cannabis).  They are also disparaging of the 
lack of movement on the promised public health education campaign 
that was pledged when the Home Secretary announced the maintenance 
of the status quo in relation to cannabis remaining a Class C drug in 
January 2006.  This is contrasted unfavourably with the French 
Government spending €3.8m on a communications campaign about 
cannabis in 2005.  Rethink is also lobbying for:  
x Drugs education in schools about the mental health effects of 
cannabis. 
x Protection and information for people with severe mental illness. 
x More investment in services for people with cannabis dependence 
as most investment has been into drug treatment services has 
been for those with Class A dependency e.g. problem opiate use. 
x More research to clarify the link between cannabis and mental 
illness.  
This public debate continues with a further commitment from the Home 
Secretary to conduct more research into the links between cannabis and 
mental health, and to review the drug classification system once again, 
at a future point. 
4.4 Some Alternatives in International Cannabis policy 
 
In compliance with international drug treaty obligations, Dutch law 
states unequivocally that cannabis is illegal yet in 1976 the Dutch 
adopted a formal written policy of non-enforcement for violations 
involving possession or sale that was formally limited in 1995 to 5g limit 
for possession and a 500g limit on trade stocks through "coffee shop" 
outlets.   The primary focus in the Netherlands has been on harm 
reduction leading to a government decision to control drug markets 
according to the perceived risk of different drugs.  The risks associated 
with cannabis use has been perceived as socially acceptable leading to its 
being separated from other more dangerous drugs such as heroin or 
cocaine.  These laws are aggressively enforced, and outlets cannot 
advertise, sell to minors, deal in other drugs on the "coffee shop" 
premises, exceed their stock limit or have public disturbances arise in 
their neighbourhoods arising from their trade. 
The Dutch experience is a mixed one in that the commercialization of 
cannabis has promoted its further use (MacCoun & Reuter, 2001).  
Although the consumption of cannabis is subject to sanction, its supply 
retains the broader criminal element with ongoing fears that organised 
crime avails of the relaxation in relation to cannabis to hide trafficking in 
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more dangerous drugs.  Adjoining European countries have complained 
about "drug tourism" which has lead to stricter internal Dutch controls 
being introduced and the overall number of "coffee shops" that had 
grown with the initial relaxation in the law being have been reduced by 
50%.  Dealing in more dangerous drugs is not tolerated and lengthy 
prison sentences can be imposed (Ghodse, 2002). 
 
Certain states of the USA decriminalised cannabis in the 1970s making 
it a civil offence punishable by a fine.  States that decriminalised did not 
report an increase in consumption in comparison to states that did not, 
apart from Alaska where 12-17 year olds were found to be smoking 
cannabis at twice the national average, after decriminalisation (CASA, 
1995).   
 
4.5 Irish Views 
 
Interviewees in the National Advisory Committee on Drugs (NACD) study 
in 2002 were asked whether or not “people should be permitted to take 
cannabis for recreational reasons”.  Overall, only 21% of the Irish 
population indicated that this should be permitted.  Interestingly only 
60% of the past cannabis users endorsed this statement.  A similar 
finding was noted in a survey of public opinion regarding cannabis 
conducted in 2001. One in seven people thought that cannabis should be 
legalised for recreational use (Sinclair et al, 2001). In another nationwide 
study of public opinion in 1999, involving 1000 adults, 24% agreed that 
cannabis should not be against the law (Bryan et al, 2000). 
 
The vast majority of Irish people (69%) disapprove of people smoking 
cannabis occasionally (NACD, 2005a). Again, a substantial minority 
(23%) of those who had smoked cannabis in the past now disapproved of 
people smoking cannabis occasionally.  With regard to the perceived risk 
to smoking cannabis regularly, the majority of the Irish population 
perceived this risk to be at least moderate (83%).  This rose to 87% 
among the adults who had never used cannabis.  Among those who had 
tried cannabis at least once in the past, 62% perceived the risk with 
regular use to be at least moderate.  Earlier research indicated that 
younger people perceive much less danger in cannabis than older people 
in Ireland (Bryan et al, 2000). 
 
In rejecting suggestions that Irish law should be changed in regard to 
cannabis to mirror the British decision, Noel Ahern TD, Minister of State 
with responsibility for the National Drugs Strategy stated in late January 
2004 that, “We’re quite happy with how the law stands... In the UK, even 
after reclassification, in theory you can still get a tougher prison sentence 
than here, so in many ways they are more or less coming into line with 
how we are”. 
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In July 2004 Junior Health Minister Tim O´Malley who has responsibility 
for the Mental Health portfolio warned against the dangers of any move 
to reclassify cannabis in Ireland. Minister O´Malley claimed in a press 
release5 that the recent decision by the UK authorities to downgrade 
cannabis to a Class C drug should not be repeated here. 
Minister O´Malley, claimed that the abuse of cannabis in Ireland was 
having a detrimental effect on the mental health of users and that he 
could see a rise in serious mental health problems in the years ahead. 
"According to recent findings of the National Advisory Committee on 
Drugs (NACD), cannabis is the most widely abused drug in this country, 
with prevalence rates at least twice as high as other illegal drugs. This 
widespread abuse raises serious concerns about the damage being done 
to users, especially to teenagers and young adults." 
"Cannabis has been associated with the increased risk of developing 
schizophrenia in otherwise healthy individuals. The increase of risk is 
directly associated with an increase in frequency of use." 
Minister O´Malley claimed that the reclassification of cannabis in the UK 
sends out the wrong message to users that this is a ´safe´ drug and that 
it can be used with impunity. "Greater education, as opposed to 
reclassification, must continue to be the Government´s response. Most 
young people remain unaware of the potential dangers to their mental 
health caused by using cannabis and think they can smoke this drug 
recreationally without any long-term consequences." 
4.6 A parent's perspective 
The Observer journalist Sue Arnold, who has the chronic eye condition, 
retinitis pigmentosa initially championed cannabis after crediting it with 
saving her eyesight but has changed her view on cannabis after her 
college-age son "had what psychiatrists call 'a psychotic episode,' 
triggered by cannabis…my son spent six months in hospital in an 
intensive care unit (ICU). He was prescribed different drugs and, after a 
series of events which are too difficult and painful to describe, has just 
resumed his final year at university. He's still on medication and will 
probably have to take it for ever. It goes without saying that if he ever 
                                                 
5
 UK Cannabis Change should not be followed in Ireland - O´Malley: Junior Health 
Minister warns of mental health dangers associated with drug, issued by the 
Department of Health & Children. 
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smokes another spliff he will have a relapse." (Observer 18, January 
2006) 
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5. Cannabis and Mental Health 
 
 
5.1 Introduction 
 
It has long been recognized that there is a association between 
cannabis use and mental illnesses such as depression, suicidal thoughts 
and schizophrenia. However for many years it was assumed that 
individuals who were already depressed or psychotic were more likely to 
take cannabis rather than cannabis having a causal role in these 
disorders. This question has been extensively researched over the past 
few years and the balance of opinion among psychiatrists has now 
shifted to the view that cannabis smoking is a causative agent in the 
development of psychosis and depression for some people. In January 
2006 the Advisory Committee on Misuse of Drug (UK) concluded in a 
report on cannabis that .. ‘ The mental health effects of cannabis are real 
and significant’ (see section 4.3).   In addition there is now growing 
evidence that the earlier the onset of cannabis use the stronger the link 
with mental illness. This evidence is reviewed below. 
 
5.2 Psychosis 
 
5.2.1 Definitions 
  
x Psychotic symptoms: 
Psychotic symptoms are defined as delusions (abnormal beliefs); 
hallucinations (abnormal perceptual experiences) and disordered 
thinking. Many people (up to 20% of the population) may experience 
psychotic symptoms at some time during their lives. 
 
x Schizophrenia 
Schizophrenia is a serious mental illness affecting 0.5-1% of the 
population over the course of their lifetimes. In addition to psychotic 
symptoms (see above), individuals with schizophrenia characteristically 
have other problems such as loss of motivation, disturbances of 
behaviour, and cognitive deficits. These symptoms tend to be enduring 
and disabling. Full recovery from schizophrenia occurs in only about 10-
20% of sufferers.  Treatment of schizophrenia accounts for a significant 
proportion of the mental health budget. Costs are also associated with 
lost years of productivity  due to the early onset of the condition. 
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x Schizophreniform disorder 
This is a condition in which all the diagnostic criteria for schizophrenia 
are met but symptoms have persisted for less than six months. For some 
it is a transient condition from which they make a full recovery. For 
others it progresses to schizophrenia.  
 
 
5.2.2 Cannabis use among patients with schizophrenia 
 
There is clear evidence that use of cannabis worsens the symptoms 
of schizophrenia, increases the risk of relapse and worsens outcome 
(Linzen et al, 1994, Grech et al, 2005). Unfortunately there is a very high 
prevalence of cannabis use among patients with schizophrenia. The 
reasons for this are, as yet, unknown. It is thought that cannabis may 
induce an immediate anxiolytic effect whereas the effects on worsening of 
psychotic symptoms are delayed. The high prevalence of cannabis use 
and associated problems with illicit drug dealing are a problem in many 
psychiatric institutions and difficult to control. 
 
5.2.3 Can cannabis cause schizophrenia? 
 
The question of whether cannabis use can ‘cause’ or contribute to 
causing schizophrenia has been a controversial issue for many years. 
Although suspected for decades, only recently has strong evidence 
emerged to support a causal association. The psychiatric and scientific 
community initially rejected this association but there has been a change 
of opinion over the past four years based on the emergence of new data 
from large prospective epidemiological studies (Arseneault et al, 2002; 
Van Os et al, 2002; Zammit et al, 2002; Henquet et al, 2005). This 
evidence is summarized in Table 5.1 (below). Essentially all studies 
which have specifically examined this issue have shown that cannabis 
use confers an increase in risk for later schizophrenia outcomes.  
 
The issue of whether cannabis use is merely a manifestation of a 
preexisting early psychosis has been addressed by two studies. (1) The 
study by Arseneault et al (2002) was able to adjust the relationship 
between cannabis use at age 15 and later schizophreniform disorder for 
the prior presence of psychotic symptoms at age 11. The results showed 
that there was still a three-fold increase in risk for later schizophreniform 
disorder among adolescent cannabis users even when individuals with 
prior psychotic symptoms were excluded from the analysis. Henguet et al 
(2005) also showed that adolescents with no prior symptoms were at 
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increased risk of later psychosis if they used cannabis in adolescence 
compared with adolescents who had not used cannabis.  
 
Three meta-analyses (ie analyses that pool together the results 
from similar studies examining the same question) (Henquet et al, 2005; 
Semple et al, 2005; Arseneault et al, 2004) examining this association 
between cannabis use and later psychosis have been published since 
2004.  
1) Arseneault et al (2004) found a pooled odds ratio of 2.3 (ie 
2.3 fold increase in risk) and concluded that ‘Cannabis 
use is a component cause …part of a complex 
constellation of factors leading to psychosis’ 
2) Semple et al (2005 ) found a pooled odds ratio of 2.9 and 
concluded that ‘The available evidence supports the 
conclusion that cannabis is an independent risk factor 
both for psychosis and for the development of psychotic 
symptoms’ 
3) Henguet et al (2005) found a pooled odds ratio of 2.1 and 
concluded that ‘Cannabis is a component cause in the 
development of psychosis.......in which gene-environment 
interactions are most likely to explain this association’.  
 
One review of psychological and social sequelae of cannabis and 
other illicit drug use by young people (MacLeod et al, 2004) concluded 
that ‘Available evidence does not strongly support an important causal 
relation between cannabis use by young people and psychosocial harm 
but cannot exclude the possibility than such a relation exists’. This review 
was not a meta-analysis and the interpretation of their results has 
proven controversial.  
 
 
Case History  
Sam, the 27-year-old son of mental health worker, Tom, began smoking 
cannabis at 16, graduated to smoking up to 10 joints a night over 
weekends, and then, in his twenties, was diagnosed as schizophrenic.  
'Sam was a brilliant sportsman: a gifted footballer, a superb runner, a 
natural athlete,' says his father. 'Now, he is just a shadow, a recluse. This 
is definitely an emerging issue. Everyone knows a "dope head" who has 
used cannabis, the "safe" drug. It's not just the number of cases of 
schizophrenia and psychosis that's a concern, it's the thousands upon 
thousands who have lost a future.’ 
Tom now campaigns for greater public awareness of the adverse 
psychological effects of cannabis. 
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Case History 
 
John, a 22 year-old student developed paranoid delusions and a severe 
anxiety state with symptoms of derealisation and depersonalization one 
hour after smoking 'skunk'. He reported 'watching himself lying on the bed' 
and he became suspicious that his family were concealing some problems. 
He became increasingly distressed over the next eight hours believing that 
he had incurred 'brain damage' secondary to the cannabis use with an 
transient feeling of irrational anxiety and losing the perception of his body. 
Over the following two weeks there was slow resolution of his symptoms 
but the delusion of having incurred brain damage secondary to the use of 
cannabis persisted. He is currently being treated for schizophrenia having 
relapsed four months following his first presentation with acute paranoid 
delusions regarding his family. 
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Table 5.1 Prospective studies examining association between 
cannabis use and later psychosis  
 
Reference Number 
of 
subjects 
 
Age at 
baseline 
Years 
of 
follow-
up 
Outcome Odds Ratio*  
(95% CI) 
Andreasen 
et al 
(1988)  
 
45,570 18 18 Schizophrenia 2.3 (1.0-5.3) 
Zammit et 
al (2000) 
 
50,053 18 27 Schizophrenia 3.1 (1.7-5.5) 
Van Os et 
al (2002) 
 
4,045 18-64 3 Psychotic 
symptoms 
2.8 (1.2-6.5) 
Arseneault 
et al 
(2002) 
 
759 15-18 11 Schizophreniform 
disorder 
3.1 (0.7-13.3) 
Weiser et 
al (2002)  
 
50,413 16-17  Schizophrenia 2.0 (1.3-3.1) 
Fergusson 
et al 
(2003) 
 
1,011 18 3 Psychotic 
symptoms 
1.8 (1.2-2.6) 
Stefanis et 
al (2004) 
 
3,500   Psychotic 
symptoms 
4.3 (1.0-17.9) 
Henguet 
et al 
(2005)  
2,437 14-24 4 Psychotic 
symptoms 
1.7 (1.1-2.5) 
 
* Adjusted for social factors, other drug use, IQ  and prior 
psychotic symptoms (if data available)
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5.2.4  How big is this effect? 
 
Cannabis use appears to cause a 2 to 3-fold increase in the risk of 
later schizophrenia outcomes.  
 
It is estimated that cannabis use is a factor in the development of 
schizophrenia in 8-10% of all cases of schizophrenia. This means, for 
example, that 25,000 of the 250,000 people with schizophrenia in the UK 
could have avoided the illness if they had not used cannabis (Murray, 
2006). It seems safe to assume that cannabis use accounts for a 
similarly high proportion of schizophrenia cases in Ireland, given the 
high rates of cannabis use found here (see Epidemiology chapter).  
 
5.2.5 Who is most at risk? 
 
x Teenage users: Adolescent-onset cannabis use confers an even 
higher risk of later schizophrenia – about four-fold (Arseneault et 
al, 2002). The earlier the age at starting cannabis use the higher the 
risk. Arseneault et al (2002) found that those who were using  
cannabis by age 15 were at higher risk of later psychosis than 
those who started after age 15. In fact 10% of the adolescents who 
were using cannabis at age 15 were later diagnosed with 
schizophreniform disorder. This is particularly worrying given the 
high rates of teenage cannabis use in Ireland and the continuing 
decrease in the age at initiating cannabis use (see section 3.5) A 
recent survey carried out in collaboration with the World Health 
Organisation (WHO) found that one in every four boys and one in 
every seven girls in Ireland aged 15 years reported using cannabis 
in the year prior to the survey (Collins et al, 2004). 
 
 
Case History 
James, in his twenties, began smoking cannabis at 15. 'The reason I never 
did any other drugs was because their dangers were well known. I was a 
sensible person,' he said, aware of the irony. 'Even when I went to two 
GPs, saying I was having problems with anxiety and paranoia, they gave 
me antidepressants and said if the cannabis helped me to relax, I should 
carry on.'  
At 19, he had a breakdown and was hospitalised with drug-induced 
psychosis. At school, he achieved good exam results. Now he is unable to 
hold down a job. 'My brain works but I don't do well in social situations. If 
only I'd known about the risk.' 
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Case History 
Martin is a sixteen-year-old boy who was initially placed in care by his 
mother when he was eight years old.  He has been prone to angry 
outbursts throughout his life.  His mother has a history of depression and 
alcohol abuse, with many instances of self-harm over the years.  Due to 
his difficulties, Martin has had multiple changes in school since early 
childhood and he finally dropped out at the age of 14 years. He has had 
multiple foster care placements, with occasional periods back at home with 
his mother. These changes to his living arrangements and haphazard 
schooling have resulted in difficulty in forming peer relationships and 
difficulty in trusting adults. 
 
He began smoking cigarettes at the age of 11years and has been getting 
drunk on an intermittent basis from the age of 12 years.  He began 
smoking cannabis at the age of 13 years and his cannabis use has 
persisted.  In the past year he has been smoking it on a daily basis.  In the 
past two months he has become quite paranoid in his latest care 
placement.  He believes that he is being observed through a two-way 
mirror in his bedroom and believes that his bedroom is bugged.  He has 
heard voices criticising him when there is no one in the room.  He is 
becoming increasingly distressed by these thoughts.  He says that he has 
been using cannabis to help him relax and to deal with this distress. 
 
 
x People with a tendency to psychosis: A large prospective study 
of 2437 young people from Germany found that cannabis use 
increased the risk of psychotic symptoms generally but there was a 
much stronger effect in young people who had evidence of 
predisposition to psychosis (Henquet et al, 2005). Therefore young 
people who have already experienced psychotic symptoms (however 
mild or transient) are particularly at risk of later schizophrenia if 
they use cannabis in early adolescence. 
 
x Genetic vulnerability: A recent study has shown that a common 
genetic profile, present in about one-in-four of the population (the 
val/val allele of the COMT genotype) confers a large increase (about 
10-fold) in the risk of developing later schizophrenia-related illness 
if one begins to use cannabis in adolescence (Caspi et al, 2005).  
This effect size is equivalent to the size of the association between 
smoking and lung cancer. Interestingly this gene-environment 
interaction effect is not seen in those who begin using cannabis 
after the age of 18.  
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5.2.6 What kind of cause is it? 
 
The studies reviewed earlier (see Table 5.1) show that cannabis use is not 
a necessary cause for the development of schizophrenia as not all adults 
with schizophrenia have used cannabis previously.  
 
It is also clear that cannabis use is not a sufficient cause for 
schizophrenia because the majority of adolescent cannabis users do not 
develop schizophrenia in adulthood.  
 
Therefore it is likely that cannabis is a component cause, among possibly 
many others, that form part of the causal constellation leading to 
schizophrenia.  
 
Estimates of the population risk attributable to cannabis suggest that 
cannabis could account for about 8-13% of psychosis. The task of 
deciding the harms of cannabis is essentially a ‘choice of evils’ in which 
the rights of the majority to use cannabis without experiencing problems 
are balanced against the risks for a significant minority (about 10% of 
adolescent users) who may develop serious mental health consequences. 
 
 
5.3 Depression and Suicide 
 
There is a high rate of depression among those seeking treatment for 
cannabis dependence and the rate of cannabis use is higher among those 
being treated for depression (Degenhardt et al, 2001; Chen et al, 2002). 
Longitudinal research conducted in the United States, Australia and New 
Zealand has provided evidence of a causal connection between cannabis 
use and depression.  
 
There is a higher rate of cannabis use among those making a serious 
suicide attempt (Beautrais et al, 1999). 
A large twin study from the US has shown that the twin who was 
dependent on cannabis was almost three times more likely to think about 
suicide and attempt suicide than his-her non-cannabis dependent co-
twin (Lynskey et al, 2004). 
 
5.3.1 How big is this effect? 
 
A 16-year study showed that individuals who were not depressed and 
then used cannabis were 4 times more likely to be depressed at follow-up 
(Bovasso et al, 2001).  
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5.3.2 Who is most at risk? 
 
x Adolescent users: A 14-year follow-up study showed that 
cannabis use during childhood and adolescence  increased the risk 
of later major depression by 17%. This study was one of the first to 
call attention to the psychiatric implications of early cannabis use. 
(Brook et al, 2002).   
x Frequent users (teenage): A study from New Zealand found that 
(at least weekly) cannabis use among young people was associated 
with depression, juvenile delinquency, suicidal thoughts and 
suicide attempts by age 21 years (Fergusson et al, 2002).   
x Teenage girls: Another New Zealand study (Patton et al, 2002) 
found that daily use of cannabis increased the risk of depression 
five times among teenage girls.  
 
 
Case history 
Billy began drinking alcohol at the age of 10, having grown up in a home 
where his father and grandparents were heavy drinkers.  Within a year he 
and his friends were also smoking tobacco and cannabis.  At the age of 16 
his behaviour changed and he began to falsely accuse his younger siblings 
of interfering with his belongings, picking fights with them that sometimes 
ended in violence.  This lead to a lot of rows at home and his parents 
threatening to throw him out unless his behaviour improved and his drug 
taking stopped.  Billy disappeared and his body was recovered from the 
sea 2 weeks later. At postmortem significant levels of alcohol and 
cannabis were found in his blood. 
 
Case History  
 
Earlier this year 23-year-old Roy died after bingeing on methadone and 
cough medicine.  The coroner underlined the tragic downhill spiral that 
cannabis dependency can produce in a mentally ill person. Roy had begun 
to smoke joints at age 14 and eventually moved on to ‘skunk’. He was 
diagnosed as schizophrenic at 19. 'The use of cannabis exacerbated his 
mental health problems,' the coroner said. 'It predisposed him to smoking 
more regularly than was good for him.'  
Roy's sister, Lisa, said: 'It was horrible. He was sectioned at 19 when it 
should have been the best time of his life. He had been a bright boy at 
school. One doctor told my mother that the increasing use of skunk had 
created a ticking time bomb.'  
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5.4 Effects of cannabis on intellectual functioning 
 
Over the last 30 years numerous studies have examined the 
psychological consequences of cannabis use. Of particular interest has 
been the investigation of whether there are any long-term cognitive 
effects associated with cannabis use and if so, what is the nature of 
these effects.   
 
Recent studies have shown that mathematical and verbal skills as well 
as attention, information processing and motor functioning have all been 
affected in chronic cannabis users compared to non-users. These effects 
persist after wash-out periods of between 7 and 31 days.  
 
A series of studies by Solowij et al (1995; 1998; 2002) found that 
cannabis users were poorer than controls at filtering irrelevant 
information and recalled fewer items on verbal learning tests. These 
effects were not due to acute intoxication as users abstained from 
cannabis for 24 hours prior to testing and were found to worsen with 
years of regular cannabis use. Similarly Pope & Yurgulun-Todd (1996) 
found college students who were heavy cannabis users differed from non-
users on tests of digit span, auditory processing, short-term memory and 
attention. In a further study Pope et al (2001) found that current heavy 
users performed significantly worse than controls on memory tasks after 
a 7 day abstinence from cannabis.  
 
Bolla et al, (2002) found that heavy cannabis users were impaired 
compared to controls on measures of memory and manual dexterity even 
after a 28 day wash-out period. Messinis et al (2006) required users to be 
abstinent from cannabis for at least a 24 hour period and found that 
cannabis users were impaired on measures of verbal fluency, verbal 
memory, attention and psychomotor speed.  
 
 
 
5.5 Brain structural and functional changes  
 
Brain imaging studies show evidence of impaired brain function in heavy 
cannabis users. Functional brain scans show that cannabis use affects 
activity in certain brain regions both during rest and during the 
performance of cognitive tasks. The areas most frequently reported to be 
affected are the prefrontal cortex, the hippocampus and the cerebellum. 
Jacobsen et al (2004) Bolla et al (2005)  
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These findings are consistent with studies showing that one of the major 
cannabinoid receptor sites in the human brain is in the part of the 
forebrain associated with higher cognitive functions (Glass et al, 1997).  
 
There are also actual brain structural changes associated with cannabis 
use. These changes may be more significant in those who start using 
cannabis in adolescence while the brain in still developing. One study 
(Wilson et al, 2000) has shown that those who started using cannabis 
early in adolescence had reduced grey matter in the frontal cortices 
compared to those with a later age of onset.  
 
 
5.6 Cannabis and Prenatal Brain Development 
 
Based on data from the Unites States cannabis is the most commonly 
used illicit drug by women of reproductive age and its use appears to 
increasing among this demographic group.  
 
There is accumulating evidence that prenatal exposure to cannabis leads 
to the development of neurobehavioural and cognitive deficits (Hutzinick 
et al, 2006; Fried et al, 2003; 2001).  
 
The strongest evidence comes from animal research which has shown 
that, cannabinoids administered to rodent mothers reach the brain of 
fetuses in substantial amounts due to the immaturity of the blood 
barrier. These studies have shown a resulting effect on the maturation of 
specific neurotransmitters leading to irreversible effects on behaviour and 
brain structure (Fernandez-Ruiz et al, 2000).  
 
In humans, two longitudinal studies have found similar effects of heavy 
cannabis use during pregnancy. The Ottawa Prenatal Prospective Study 
(OPPS; Fried et al, 2002) used a sample of white, middle class families 
while the Maternal Health Practices and Child Development Study 
(MHPCD; Richardson & Day, 1998) used a sample of low-socioeconomic 
status families, a substantial number of whom were African American.  
 
Both studies found considerable and persisting impairments of executive 
functions of the offspring prenatally exposed to cannabis.  Specific 
abilities affected at follow-up were problem solving, sustained and 
focused attention, working memory and abstract and visual reasoning.  
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5.7 Age, Amount and Duration of Use 
 
Important factors affecting the impact of cannabis use on both cognitive 
functioning and mental health outcomes are the age at which cannabis 
use is initiated, the amount used and the subsequent duration of that 
use.  
 
5.7.1 Consequences of adolescent onset cannabis use 
The data from many of the studies mentioned in previous sections clearly 
shows the significance of starting to use cannabis in early adolescence 
compared to onset in adulthood. Pope et al (2003) found that those who 
began smoking cannabis before the age of 17 were impaired on verbal IQ 
measures compared to controls. Arseneault et al, (2002) showed that 
adolescent onset cannabis use led to a four fold increase in the risk of 
developing schizophrenia; twice the odds normally quoted for onset in 
adulthood. Lynskey et al (2004) found that early onset use increased the 
risk of subsequently attempting suicide and Wilson et al (2000) found 
that those who started using cannabis before age 17 had a lower 
percentage of cortical grey matter compared to those who started later in 
life. Since the brain (particularly the frontal cortex) continues to develop 
during adolescence it is possible that cannabis may be exerting a 
neurotoxic effect of cannabis on the developing brain. Since cannabis use 
before age 12 is still rare the main evidence for neurotoxicity in humans 
will come from studies of adolescent users and prenatal exposure.  
 
 
Case History 
 
Daniel is 23, articulate, musically talented and academically bright. At the 
age of 19, after several years of feeling depressed, anxious and 
increasingly disconnected, he was diagnosed as having Asperger's 
syndrome, a form of autism.  
Last September, after 18 months in a residential unit, Daniel decided to 
return to university. After several weeks at college, he began to do what he 
has always done, since the age of 15, to ease the feelings of alienation - he 
began to smoke cannabis excessively.  
He gives a long and moving account of life with a cannabis addiction. 'At 
first, with cannabis, it becomes so much easier to float by unnoticed. But 
then you become paranoid. You're quick to assume the world isn't going to 
make a place for you.’.  
'In my teens I used to champion cannabis but once you've taken yourself to 
places I've taken myself to, you can't hide from what your brain felt. Now, I 
don't get a high at all. Instead, my brain hurts so much, and I don't sleep 
for days. It goes wrong so quickly that what's going on internally becomes 
visible to everyone and that's frightening for me. No one at 23 who's been 
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into cannabis for years can get away with saying it doesn't mess your 
head up.  
 
 
 
5.7.2 Dose and duration related effects 
There is evidence of dose-related neurocognitive effects of cannabis use. 
In other words, as people use more cannabis over time they are more 
likely to demonstrate long lasting impairment in brain functioning. 
Skosnik et al (2001) found that prefrontal cortical functions were not 
disrupted by low doses of cannabis. Bolla et al (2002; 2005) found that 
performance on measures of memory and executive function deteriorated 
as joints per week increased and that heavy users (53-84 joints/week) 
compared to moderate users (8-35 joints/week) and controls had 
significant alterations in prefrontal brain activity. Similarly, Degenhardt 
et al, (2003) found, in a review of the literature, that there was only 
evidence for an association between depression and cannabis use at the 
heaviest, most frequent use end of the spectrum. 
 
While the factors of use duration, frequency and amount are confounded 
in most studies, recent findings show that duration of use exerts an 
independent effect. Messinis et al (2006) compared neuropsychological 
functioning in long and short term heavy users and found that long-term 
users performed worse than short term users on measures of verbal 
memory and psychomotor speed.  
 
 
 
 
5.8 Summary and Conclusions 
 
There is strong evidence from large prospective studies of a causal link 
between cannabis use and mental health problems, with the strongest 
evidence for an association with schizophrenia.  
 
There is also considerable evidence for long-term, detrimental effects of 
chronic cannabis use on cognitive (intellectual) function. Heavy use has 
been associated with impaired verbal skills, memory, attention and 
information processing.  
 
There is particular concern about the effects of cannabis use on the 
developing brain (ie in adolescent users and those exposed prenatally). 
There is some evidence that exposure during these vulnerable periods 
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may lead to higher incidence of later mental illness and significant and 
lasting effects on intellectual functioning. 
 
In summary cannabis use before age 17, as well as greater amounts and 
longer duration of cannabis use, all confer specific risk for impaired 
cognitive function and mental illness later in life.  
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6. Physical Aspects  
 
6.1 Introduction 
 
Irish 16 year olds have twice the rate of lifetime cannabis use compared 
to the average among the other European countries6 and 17% of the 
general population has used cannabis at some stage in their life.  The 
major motive for our widespread recreational use of cannabis is the 
experience of a subjective "high" - an altered state of consciousness 
which is characterised by emotional changes, such as mild euphoria and 
relaxation; perceptual alterations, such as time distortion, and; 
intensification of ordinary sensory experiences, such as eating, watching 
films, listening to music, and engaging in sex. When used in a social 
setting, the "high" is often accompanied by infectious laughter, 
talkativeness, and increased sociability.  
 
6.2 Intoxication Effects 
 
Cannabis affects almost every body organ.   It combines many of the 
properties of alcohol, tranquillisers, opiates and hallucinogens; it is 
anxiolytic, sedative, analgesic, psychedelic; it stimulates appetite and has 
many systemic effects (Ashton, 2001). 
 
The physical effects experienced by a user of cannabis will depend on the 
amount taken, the potency of the product, the mode of administration 
and the user's prior experience with the drug and whether any other 
drugs are being used concurrently.  The user's expectations, mood state 
and attitudes towards the drug effects and the setting in which the drug 
is used are also important. In a major all-Ireland study of cannabis use 
published by the National Committee on Drugs in late 2005 it was 
revealed that the potency of cannabis available in Ireland has increased 
in recent years, increasing the risk of dependence and psychiatric 
problems (NACD, 2005a). 
 
Cognitive changes are usually marked during a "high". These include an 
impaired short-term memory, and a loosening of associations, which 
make it possible for the user to become lost in pleasant reverie and 
fantasy, while making it difficult for the user to sustain goal-directed 
                                                 
6 Investing in Parenthood: The Supporting Parents Strategy.  Best Health for Children 
HEBE publications, 2002 
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mental activity. Motor skills, reaction time and motor coordination are 
also affected so many forms of skilled psychomotor activity are impaired 
while the user is intoxicated. 
 
Not all the effects of cannabis intoxication are welcome. Some users 
report unpleasant psychological reactions, ranging from a feeling of 
anxiety to frank panic reactions and a fear of going mad.  A depression of 
mood is also described. These effects are most often reported by 
inexperienced users who are unfamiliar with the effects of cannabis. 
More experienced users may also report these effects on occasion, 
especially after consuming cannabis when the effects may be more 
pronounced and of longer duration than those usually experienced after 
smoking cannabis.  
 
Psychotic symptoms, such as delusions and hallucinations occur at very 
high doses of THC and in susceptible individuals at lower doses.  
 
Cannabis has effects similar to alcohol and benzodiazepines (minor 
tranquillisers) on the performance of tasks, including both thinking and 
motor coordination. It impairs concentration and short-term memory, 
slows reaction times, and impairs coordination. It will therefore reduce 
the ability to perform skilled tasks such as driving. After alcohol, 
cannabis is the drug most commonly found in drivers following fatal 
accidents.  
 
Case History 
 
Michael is a 28-year-old accountant.  Last weekend while on a trip to 
Amsterdam with his soccer team, he and three of his friends purchased 
some cannabis in a ‘coffee shop’.  He was first introduced to hash at the 
age of 16 years, when his best friend was given some cannabis by an 
older brother. He had also smoked hash on a few previous occasions with 
friends while at college. On these previous occasions Michael found that 
cannabis made him quite tired and a little bit more relaxed. 
 
However, after smoking cannabis in his hotel bedroom on his trip to 
Amsterdam, he found the experience to be very unpleasant.  His heart was 
racing.  He felt very anxious and was frightened about sitting up.  He 
insisted that his friends call a doctor.  A doctor subsequently arrived at the 
hotel and gave him a sedating tablet which helped him to relax.  Michael 
has decided never to smoke cannabis again.  Although frightened by the 
incident his mood and mental state have normalised completely. 
 
 
6.3 Respiratory Effects 
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The smoke from herbal cannabis preparations contains all the same 
constituents as tobacco smoke, apart from nicotine, including carbon 
monoxide, bronchial irritants, tumour initiators, tumour promoters and 
carcinogens (British Medical Association 1997). As a result, cannabis 
smokers experience the same health problems as tobacco smokers, 
including bronchitis, emphysema, and lung cancer.  It is estimated that 
up to four times the amount of tar can be deposited on the lungs by 
smoking a cannabis joint compared to a standard tobacco cigarette. 
Cannabis smoke contains more carcinogens than tobacco smoke leading 
to bronchitis and a doubling of the risk of certain types of cancer.  The 
way that a cannabis joint is smoked with deep and prolonged inhalation, 
the absence of a filter and the higher combustion temperature than 
tobacco contribute to this potential for lung damage. Compared with 
smoking tobacco, smoking cannabis entails a two thirds larger puff 
volume, a one third larger inhaled volume, a fourfold longer time holding 
the breath, and a fivefold increase in concentrations of 
carboxyhaemoglobin (Wu et al 1988). The products of combustion from 
cannabis are thus retained to a much higher degree. 
 
It has been calculated that smoking 3-4 cannabis cigarettes per day is 
associated with the same evidence of acute and chronic bronchitis as the 
same degree of damage to the bronchial mucosa as 20 or more tobacco 
cigarettes a day (Benson & Bentley, 1995).   
 
In a 2003 study, researchers in England found that smoking 3-4 
cannabis cigarettes a week for less than six years causes a marked 
deterioriation in lung function when comparing non-smokers, tobacco 
smokers and those who smoked cannabis.  These findings are important 
in young individuals in which the use of cannabis is increasing and may 
have serious long-term implications for what is currently regarded as a 
relatively harmless recreational habit (Nuttall et al, 2003). 
 
A striking feature of cannabis smoking is that it is associated with 
bullous lung disease in young people (Johnson et al 2000). Inflammatory 
lung changes, chronic cough, and chest infections are similar to those in 
cigarette smokers, but may also be commoner in younger people (Roth et 
al 1998). Premalignant changes have been shown in the pulmonary 
epithelium, and there are reports of lung, tongue, and other cancers in 
cannabis smokers (Henry et al, 2003).  
 
Case History 
 
Jim is a 46 year old married carpenter with three teenage children who 
has been a regular cannabis smoker since his early teens, and has 
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always found this use an aid to relaxation.  He developed a persistent sore 
throat and sensation of "pressure" in his palate that was unresponsive to 
routine medical treatment and was referred on to an Ear Nose & Throat 
specialist.  A rare tumour was discovered is his palate on MRI scan that 
has made a moderate response to treatment7.    
 
 
6.4 Cardiovascular Effects 
 
Cannabinoids most commonly produce effects on the heart and vascular 
system that are dose related.  The most immediate effect of cannabis use 
by all routes of administration is an increase in heart rate of 20-50% 
which occurs within a few minutes to a quarter of an hour and lasts for 
up to three hours.  This may reach rates of up to160 beats/minute or 
more but tolerance develops with frequency of use.  Changes in blood 
pressure also occurs which depend upon posture - blood pressure is 
increased while the individual is sitting and decreases when standing. A 
sudden change in posture from lying to standing may produce a drop in 
blood pressure and fainting, an effect which may explain the feeling of 
"light-headedness" and faintness that is often the earliest indication of 
intoxication in inexperienced users.   In healthy young cannabis users 
these cardiovascular effects are unlikely to be of any significance 
although they may magnify anxiety in inexperienced users.  
 
Cannabis-induced effects on the heart and blood pressure as described 
above may contribute to the panic attacks sometimes experienced by 
naive users who may interpret the palpitations and the feeling of 
faintness as indicators of impending misadventure, thus magnifying any 
pre-existing anxiety feelings in a vicious circle that leads to a panic 
attack.  These and other cardiovascular effects may carry a risk for 
individuals with pre-existing cardiac disease and several cases of acute 
and sometimes extremely serious cardiac incidents may occur in young 
cannabis smokers, although there are no records of fatal overdose of 
cannabis. 
 
 
6.4 Other effects of cannabis use 
 
Impaired motor coordination, hunger, and an increased desire for sugar 
rich foodstuffs also occur. It can reduce sperm production, disrupt the 
menstrual cycle, and affect intrauterine growth leading to an increased 
risk of low birth weight babies in cannabis using mothers.  There is also 
a widespread dilatation of blood vessels and reddening of the 
conjunctivae - red eyes being a characteristic sign of cannabis use.   
                                                 
7 Such tumours have been attributed to chronic persistent cannabis use. 
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6.5 Therapeutic uses of cannabis 
 
Cannabis has many pharmacological actions and it is effective in treating 
several medical conditions. These include nausea associated with cancer 
chemotherapy, loss of appetite and physical wasting associated with 
AIDS, the serious eye condition, glaucoma, muscle spasms occurring in 
multiple sclerosis and other disorders that produce involuntary muscle 
contractions, chronic pain, and migraine headaches (British Medical 
Association, 1997). 
 
Despite the fact that cannabis has some beneficial health effects, these 
should not be considered in isolation from its negative health 
consequences. Even if the active ingredient within cannabis (THC) does 
demonstrate effectiveness in treating some medical conditions, it seems 
inevitable that administration will not be via the smoked route of use. 
Oral administration would provide safer and more consistent delivery of a 
fixed dose. It would then need to undergo the same rigorous research 
investigation as other medications in order to confirm its efficacy and to 
demonstrate its safety. Given the growing evidence of neurological and 
psychiatric harm associated with cannabis use, it seems very unlikely 
that the safety profile will be seen to be acceptable. 
 
Case History 
 
Eoin developed Multiple Sclerosis in his early 30s and this condition 
progressed very slowly in the early years.  He refused Interferon treatment 
in 2001 and opted instead to have a series of "holistic" alternative 
treatments, using cannabis to reduce muscle pain and spasm, eventually 
leading to daily heavy cannabis use.  He developed a fear and suspicion 
that his life was in danger from his carers and began telephoning the 
Gardaí and emergency services to come to his aid several times each night 
eventually culminating in referral to his local mental health services and 
an involuntary hospital admission. 
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7. Social harm 
 
7.1 Introduction 
 
All intoxicating substances are associated with some risk of social harm.  
These harms are variable in their origin; some are associated with the 
actual intoxicating effects of the substance, which can be disinhibiting 
and result in increased risk taking, while reducing psycho-motor 
performance and therefore resulting in a variety of accidents.  
Substances can also lead to emotional volatility. When this is associated 
with disinhibition, it may be manifested in violent behaviour.  Frequent 
drug use also has a negative impact on the individuals’ ability to perform 
ordinary social roles. This may include the ability to perform at work and 
in educational settings.  It can also have a negative impact on an 
individual’s ability to function in loving relationships or in parenting and 
caring roles.   
 
Although cannabis is less likely than alcohol to cause someone to 
become aggressive and engage in public order offences, its use is in itself 
illegal and funds an extensive criminal network of suppliers.  This 
criminal activity places a burden, not only on society but also on the 
criminal justice system, which is here to protect society. People convicted 
of cannabis procession may suffer socially as a consequence of the 
conviction.  
 
7.2Accidents and Risk Taking 
 
 
7.2.1 Road Traffic Accidents 
It is clear that cannabis can affect an individual’s ability to drive. 
However the association with dangerous driving and road traffic 
accidents is not as robust as the association of alcohol with these 
outcomes.  After smoking cannabis, research indicates that drivers tend 
to be quite self conscious and quite aware of their impaired abilities and 
make allowances of same.  Many people who have road traffic accidents 
after consuming cannabis have also consumed alcohol.  It is likely that 
there is a synergistic effect between these two substances, with the 
combination being more impairing than either substance alone. 
 
In 2000 and 2001, a study was conducted examining drug use by drivers 
who were stopped by gardaí for appearing to be intoxicated (Cusack et al, 
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2004). It emerged that 21% of the drivers who were under the legal limit 
for alcohol tested positive for cannabis use. Cannabis was the drug most 
frequently identified among this group, with amphetamines being the 
next most common (9%). Among those who were over the limit for 
alcohol, 9.5% were also positive for cannabis. Cannabis was detected in 
the urine of drivers under the age of 35 about four times more often than 
in the samples provided by those aged 35-44 years. The study concluded 
that “the typical profile of the driving under the influence of drugs driver 
apprehended and tested is young, male, driving in an urban area with 
low or zero alcohol level with a specimen provided between the hours of 
6am and 9pm with the presence of cannabinoids.” Unfortunately, the 
current screening tests for cannabis give limited quantitative data. 
Consequently, it will be difficult to confirm cannabis intoxication in 
criminal proceedings regarding driving offences. 
 
7.2.2 Other accidents 
 
Due to the disorientating effects of cannabis and its impairment on some 
psycho-motor functions as described in the chapter on “Psychological 
Consequences of Cannabis Use”, it is inevitable that cannabis plays a 
role in some serious accidents each year in Ireland. These may include 
falls and drownings.  
 
7.2.3 Sexual Risk Taking 
 
Cannabis is not likely to be associated with the same level of risk taking 
which is seen with alcohol. However, it may diminish users’ inhibitions 
and make them more likely to make choices which they would not make 
if there were not under the influence of a substance.  This brings with it 
the risk of unplanned pregnancies and sexually transmitted infections.   
 
7.3 Violence and Criminality 
 
7.3.1 Violence 
Cannabis is not as likely to cause violence as other substances such as 
alcohol or stimulants (e.g. cocaine and amphetamines).  However, there 
are some circumstances in which cannabis use could precipitate violent 
behaviour.  Firstly, some individuals when first introduced to cannabis 
can develop severe anxiety symptoms.  It is possible that these people 
might become aggressive as a consequence of these feelings of fear and 
distress.  Secondly it is known that cannabis use can cause acute 
psychotic episodes and can also precipitate relapses of schizophrenia.  
While only a minority of psychotic patients is violent, some people can 
become violent in response to their paranoid delusions or hallucinatory 
symptoms.  Finally, it has become clear in recent years that heavy 
cannabis users do experience withdrawal symptoms following abrupt 
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discontinuation of use (Vandrey et al, 2005).  Irritability is one feature of 
the withdrawal syndrome.  This irritability might cause some of the 
individuals to become aggressive more easily.   
 
There is a clear association between cannabis use and antisocial 
behaviour.  However, the majority of this association has its origins in 
the fact that people who are prone to anti-social behaviour are more 
likely to co-incidentally smoke cannabis.   It is very rarely the case that 
cannabis is actually the cause of the antisocial behaviour demonstrated 
by these individuals.  A recent study of Dutch adolescents demonstrated 
that a link between antisocial behaviour and cannabis use is also seen in 
societies with a more liberal attitude towards cannabis (Monshouwer et 
al, 2006). In a 1998, the Garda Síochána conducted a study to explore 
the link between alcohol or drug use and criminal behaviour (Miller et al, 
1998). They studied 4,334 criminal offences across Ireland and the 
arresting garda was asked for their “informed opinion” as to whether 
alcohol or drugs had played a role in the offence. Alcohol was identified 
as a factor in 42% of offences. In contrast, cannabis was identified as a 
contributor in just 4% of cases.  
 
 
7.3.2 Illegal Drug Market 
It is estimated that the illegal cannabis market is worth about ʫ375m 
annually in Ireland (Connolly, 2005). The cannabis market is worth more 
than the combined market for cocaine, heroin, ecstasy and 
amphetamines. While it is difficult to estimate the profits made at the 
various levels of the dealing network, it seems likely that the majority of 
this money is actual profit, which increases the wealth of main 
importers, regional suppliers and local dealers.  Given the great value of 
this market, it is not surprising that dealers will engage in violent 
behaviour and murder in order to maintain their profits.  This brings 
with it a degree of fear and intimidation in those communities where 
dealing is prominent.  Given the enormous demand for cannabis, it 
seems inevitable that this demand will be met. As each network of 
importers is imprisoned there will always be many others who are 
prepared to step in to meet the ongoing demand and take their share of 
the huge profits on offer (Connolly 2006).  
 
 
Figure 6 provides information on the volume of Garda Seizures of 
cannabis during the period 2002 to 2005. There have been substantial 
annual fluctuations. However, there has been a sustained increase in the 
volume of cannabis resin seized in recent years. It is resin which is the 
preferred form of cannabis in Ireland (see Chapter on Epidemiology). The 
large volumes of cannabis herb seized in 2001 and 2002 relate to two 
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very large seizures in Dublin port of drug which was believed to be 
destined for the UK market. 
 
Figure 6. Seizures of cannabis herb and cannabis resin in Ireland, 
2000-2005 (Garda Commissioners Annual Reports) 
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It should be borne in mind that the liberalisation of the laws regarding 
cannabis, or indeed making the use and supply of cannabis legal, will 
not eliminate the criminal supply network.  This is clear when one looks 
at the criminal activity that continues to surround supply and sale of a 
variety of legal substances on the black market, ranging from petrol to 
cigarettes and alcohol.   
 
In Holland, where there is a “legal” supply network via coffee shops, it is 
estimated that only one third of the cannabis used in Holland is sold via 
these routes.  The remaining cannabis continues to be sold through 
criminal networks (Runciman, 1999).  
 
 
7.3.3 Public Disorder 
While alcohol is an enormous contributor towards public disorder 
offences in Ireland, it appears that cannabis is a minor contributor 
public disorder (Miller et al, 1998).  This relates to the intoxicating effects 
of cannabis, which is very different to those associated with alcohol.    
 
 
7.3.4 Acquisitive crime   
Although, cannabis has a cost, it is relatively cheap.  A heavy cannabis 
user can maintain their habit at a cost of no more than ʫ60 - 70 per 
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week.  In order to put this in context, a heavy smoker who consumes 2 
packets of cigarettes per day will spend ʫ80 per week.  A drinker who 
consumes 3 pints per day will also spend about ʫ70 per week. 
Consequently, most cannabis users can fund their use through legal 
means and do not need to engage in shop-lifting, robbery or pick-
pocketing to maintain their habit.  Acquisitive crime may be an issue for 
heavy cannabis users who have no, or very little, legal income. This is 
most likely to be the case among younger teenagers who are not working 
and who do not receive pocket money.  They may engage in petty crime 
in order to fund their cannabis use.  Some heavy users may progress to 
small scale dealing of cannabis in order to maintain their use.   
 
 
7.3.5 Criminalising “Ordinary Young People” 
Among groups who criticize current legislative approaches to cannabis, 
one of their principal concerns relate to the fact that people are 
criminalised as a result of Irelands current response to the possession of 
cannabis for ones own personal use (Wodak et al, 2002).  They argue 
that this brings these individuals into contact with the criminal justice 
system and they acquire criminal charges, which may damage their 
employment prospects and complicate their ability to travel abroad, etc.  
In 2005, criminal proceedings were initiated in over 6,000 cannabis 
related cases, under the Misuse of Drugs Act (An Garda Síochána Annual 
Report 2005). About three-quarters of these proceedings involve 
possession offences (Section 3), while about one quarter relates to supply 
offences (Section 15).  A secondary consequence of the criminalisation of 
cannabis is that a substantial proportion of time spent by the police and 
the Courts is invested in dealing with cannabis possession offences. 
Some argue that society might benefit more if the resources currently 
invested in dealing with cannabis possession offences were redirected 
elsewhere.   
 
One matter that tends to be overlooked in this debate is that the majority 
of people who commence cannabis use do so under the age of 18 years 
(see Section 3.3.1).  A substantial proportion of cannabis that is 
consumed in Ireland occurs in people who are also under the age of 18 
years.  Cannabis use tends to diminish and peter out during the mid 
20’s.  Therefore, even if the law was liberalised, it is likely that under 18’s 
will still need to be treated differently and their use accounts for a 
substantial proportion of the use that occurs in Ireland.   
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Case History 
 
Jennifer is a 16-year-old girl who lives with her parents and two younger siblings.  Her 
mother is a solicitor and her father is a businessman.  Jennifer is getting on quite well at 
school and attained 8 honours in her junior cert.  She is popular with both her friends 
and teachers. 
 
In the past year she has been going out with her friends on a Saturday night.  On 
occasion this involves going to her friends houses and on other occasions this involves 
going to discos.  She always drinks alcohol with her friends on these nights.  They buy a 
bottle of vodka as a group and they mix this with orange juice.  Her parents are aware 
that she is drinking although they do not quite know the extent of her alcohol use. While 
her drinking used to cause a lot of arguments at home, her parents have become 
accepting of the fact, as she continues to get on well at school. 
 
Jennifer has a new boyfriend for the past 3 months.  Her boyfriend is 17 years old and he 
smokes cannabis at weekends. Jennifer has now begun to smoke cannabis with her 
boyfriend on her Saturday nights out, usually having a few drinks first.  Her parents are 
unaware of the cannabis use.  They continue to assume that her intoxication on return 
home is just due to alcohol. Some of her friends have begun to give out to her about her 
hash smoking telling her that she has become more boring and withdrawn. 
 
 
7.4 Role in Progression to use of other drugs? 
 
‘Stepping Stone’ or ‘Gateway’ Theory. 
It is unusual for a person to abuse drugs such as cocaine, 
amphetamines and heroin without having first tried cannabis. Cannabis 
has received much attention as a possible ‘gateway’ drug. However, it 
should also be borne in mind that it is unusual for people to use 
cannabis without having used cigarettes and alcohol first. It should also 
be noted that the majority of cannabis users do not go on to use other 
“harder” drugs.  
 
The gateway or stepping stone theories are not straight-forward 
(Zimmermann et al, 2005; Runciman, 1999). There are a number of 
proposed biological, psychological and social mechanisms behind the 
progression from alcohol/cigarettes to cannabis and then onto other 
illicit drugs. From the biological perspective, it is hypothesised that 
exposure to drugs sensitises the reward pathway within the brain to drug 
use, making further use more likely. For example, there is animal 
research which indicates that exposure to nicotine in early adolescence 
increases the rate at which animals later becomes dependent on cocaine 
(Collins & Izenwasser, 2004). From the psychological perspective, it is 
hypothesised that once people have tried drugs and enjoyed the hedonic 
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effects while not experiencing the threatened adverse effects, they will be 
more likely to chose to use other substances which are seen to be riskier 
in the future. From a sociological perspective, it is proposed that once 
people have crossed the threshold of using illegal drugs, then they will 
find themselves in contact with criminal networks and drug dealers, 
which will greatly increase the likelihood of experimenting with additional 
substances. 
 
The gateway theory implies that there is a causal relationship between 
cannabis use and subsequent use of “harder” drugs. This causal 
relationship could have its origins in the biological, psychological or 
social mechanisms outlined above. The Stepping Stone theory does not 
necessarily imply a causal relationship. It acknowledges that there is a 
range intoxicating substances available in society, both legal and illegal. 
It proposes that people tend to use these substances in quite a set order, 
failing to progress to more dangerous or harmful drugs without first 
having tried less harmful substances. It doesn’t imply that cigarette 
smoking “causes” cannabis use, nor does it imply that cannabis use 
“causes” later heroin or cocaine use. To use an analogy, most people who 
travel from Dublin to Derry will pass through Monaghan. However, it is 
not the passing through of Monaghan which “causes” these travelers to 
arrive in Derry. 
 
Figure 7 below attempts to outline the stepping stone theory 
diagrammatically. In the scenario on the left, where cannabis use is 
criminalised, people have quite a jump to make in order to move from 
alcohol use to cannabis use. However, once they have made that jump, 
they have quite a small jump to make to cocaine use, as the criminal 
consequences of use are similar and they now have access to illegal drug 
supplies. In the scenario on the right, where cannabis use is 
decriminalised, the leap from alcohol to cannabis is quite small. It is 
therefore more likely for people to use cannabis in this environment. 
However, the leap from cannabis to cocaine is substantial. 
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Figure 7. Stepping stone theory. Two different scenarios.  
 
 
Case History 
 
Catherine is a 23-year-old woman who has been using heroin from the age of 17 years.  
Her mother was also addicted to heroin but died of an AIDs related illness when 
Catherine was 14 years old.  Her father was alcohol dependent and was in and out of 
prison during Catherine’s childhood. 
 
Catherine began smoking cigarettes at the age of 10 years and she began drinking and 
sniffing aerosol cans at the age of 12 years.  She became a regular cannabis smoker at 
the age of 13 years. Around this time she began stealing her grandmother’s Valium and 
sleeping tablets and used to take these with her friends.  She tried Amphetamines and 
LSD at this time but did not like the effects. 
 
As her heroin use escalated in her late teens she began shoplifting to fund her use. She 
acquired a number of charged.  She was also convicted of travelling in a stolen vehicle. 
 
Although she was smoking heroin initially, she found that smoking didn’t take away her 
withdrawals symptoms after a couple of years of use.  It was also becoming very 
expensive to fund her use.  She switched to injecting at this time.  She entered treatment a 
few months later and remains on a Methadone treatment programme.  She has a 2-year-
old child and they live together in a flat paid for by rent allowance.  Although she is no 
longer using heroin she continues to smoke cannabis when she meets up with her friends.  
Though she left school at the age of 15 years without any qualifications she has been 
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trying to access a FAS course over the past 6 months.  However, this has been made 
difficult due to lack of crèche facilities for her daughter. 
 
 
7.5 Impact on Social Roles 
 
7.5.1 Impaired Work Performance. 
The intoxicating effects of cannabis are likely to reduce the productivity 
of users who actually smoke cannabis in a work setting.  Where 
individuals are engaged in work which involves fine motor skills and 
rapid motor responses, accidents are also be more likely to occur.   
 
 
7.5.2 Poor Educational Attainment. 
Young people who smoke cannabis perform less well academically.  The 
association between cannabis use and poor educational attainment is 
complex.  In most cases, it is likely that this association is a result of 
common antecedent risk factors.  In other words young people with the 
typical profile of poor educational attainment are also at greater risk of 
using cannabis.  However heavy cannabis use is inevitably going to 
impair concentration and thereby interfere with the ability to study and 
learn (see Section 5.4).  Given that third level students are one of the 
groups most likely to report cannabis use in Ireland, it seems likely that 
cannabis is a factor contributing to poor attainment and drop out by a 
sub-section of Irish Students (Hope et al, 2005). 
 
7.5.3 Marital Breakdown / Family Disharmony 
Cannabis use can frequently cause problems for individuals in the 
context of other important relationships.  Heavy cannabis user by one 
partner in a loving relationship may cause the non-cannabis using 
partner to grow extremely frustrated.  In such instances it can contribute 
to relationship and indeed marital breakdown.  Similarly in families 
where teenagers smoke cannabis, this can generate a substantial degree 
of upset and family rows, with parents disapproving of this use (Wodak et 
al, 2002).  Individuals who enter treatment for cannabis abuse frequently 
cite the upset caused to the family and loved ones as the main reason for 
treatment seeking.   
 
 
7.5.4 Homelessness 
In a study of homeless people recruited from Dublin, Cork, Galway and 
Limerick during 2003, it emerged that cannabis was the illegal drug most 
commonly used by this population (Lawless & Corr, 2005). Forty-three 
per cent had used cannabis in the past month. The relationship between 
cannabis abuse and homelessness is complex. While cannabis use is a 
substantial precipitator of homelessness in only a small minority of 
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cases, its use and the consequences of its use may perpetuate 
homelessness in a substantial minority of cases.  
 
 
7.5.5 Impaired Parenting 
Where adults continue to smoke further to adulthood and after becoming 
parents, it seems inevitable that their cannabis use will impair their 
ability to successfully complete their parenting roll. Where young people 
grow up in an environment where cannabis use is accepted and actively 
engaged in, these children are much more likely to progress to cannabis 
use and indeed other drug use when they move into their teenage years. 
 
 
7.5.6 Foetal Syndromes   
It seems clear that mothers who continue to smoke cannabis during 
pregnancy do cause harm to the foetus.  Babies born to cannabis using 
mothers tend to be of lower weight and have a smaller head 
circumference.  The degree of impairment is similar to that seen with 
cigarettes (Fergusson et al 2002).   
 
There are concerns that babies exposed to cannabis in utero also acquire 
subtle changes to brain structure and functioning which persist into 
childhood (see Section 5.6).  Rising rates of heavy cannabis use among 
young women in Ireland (see Section 3.3.1) indicate that the number of 
children borne following prenatal exposure to cannabis is on the 
increase. 
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8. Treatment for problem cannabis use 
 
8.1 What are the aims of specialist services for problem cannabis 
use?  
 
The aims of specialist services for problem cannabis use include 
-  Harm reduction – reducing the impact of cannabis on one's life 
-  Abstinence – stopping cannabis completely 
-  Relapse prevention – not starting to use cannabis again. 
 
8.2 Models of psychological interventions for cannabis users 
 
The process of psychological intervention includes individual, family or 
group therapy sessions. Most interventions used for cannabis 
dependence have been developed from alcohol dependence interventions 
(e.g., Miller & Gold 1989; Zweben & O’Connell 1992). The 12-step 
fellowship movements, including Alcoholics Anonymous and Narcotics 
Anonymous, have also been used by cannabis clients seeking assistance. 
Marijuana Anonymous is a developing program in the U.S. but has not 
yet been established successfully elsewhere.  
 
The most promising interventions include Motivational Enhancement 
Therapy (MET) and Cognitive Behavioral Therapy (CBT).  These Models of 
Psychological Interventions are manualised and freely available (Rees et 
al, 1998; Sampl & Kadden 2000; Cannabis Youth Treatment (CYT) 
(www.samhsa.gov.). 
 
In the past decade a number of randomized controlled trials of Cognitive 
Behavioural Therapy for cannabis dependence in which outcomes were 
confirmed by urinalysis for cannabinoids or collateral validation have 
been performed in the United States (Stephens et al, 1994) and Australia 
(Rees et al, 1998);  
 
8.3 Rationale for CBT Treatment 
 
Cognitive behavioral therapy (CBT) is designed to remediate deficits in 
skills for coping with antecedents to marijuana use. Individuals who rely 
primarily on marijuana (or other substances) to cope have little choice 
but to resort to substance use when the need to cope arises. The goal of 
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this intervention is to provide some basic alternative skills to cope with 
situations that might otherwise lead to substance use. Skill deficits are 
viewed as central to the relapse process; therefore, the major focus of the 
CBT groups will be on the development and rehearsal of skills. 
It incorporates treatment elements that have demonstrated clinical 
effectiveness with alcoholic clients into a manual of interventions aimed 
at adolescents that can be reliably delivered, monitored, and evaluated. 
The focus of CBT treatment is on teaching and practicing overt 
behaviours, while attempting to keep cognitive demands on clients to a 
minimum. Repetition is essential to the learning process in order to 
develop proficiency and to ensure that newly acquired behaviors will be 
available when needed. Therefore, behavioral rehearsal will be 
emphasized, using varied, realistic case examples to enhance 
generalization to real life settings. During the rehearsal periods, clients 
are asked to identify cues that signal high-risk situations, indicating 
their recognition of when to employ newly learned coping skills. 
 
Staff Requirements 
 
Below are the recommended credentials and prior experience 
requirements for therapists delivering MET/CBT5: 
• Therapists should have completed a graduate program for providing 
clinical mental health services or an addiction counseling certification 
program.  Some individuals who have completed a bachelor’s degree in 
an area related to mental health can become effective providers of 
MET/CBT5. However, it is likely that they will require more intensive 
training and supervision to achieve competency. 
 
MET/CBT5 therapists. 
 
x Therapists should have a minimum of 1 year’s clinical experience 
working with adolescents. 
x Therapist experience in the following areas is also desirable: 
x Working with substance abuse issues 
x Providing behavioral and/or cognitive behavior interventions 
x Providing manual-based therapy. 
 
Therapists with experience in these areas are likely to learn the 
MET/CBT5 intervention quickly. 
The following recommended caseloads are considered ideal for 
implementing MET/CBT5 in a clinical setting.  
One full group of six participants is likely to require approximately one-
quarter of a full-time staff person’s time (approximately 10 hours per 
week).  
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For a full-time person who is only seeing MET/CBT5 participants, it is 
recommended that the caseload be limited to 3 full groups (or 18 
participants) rather than 4 full groups, because of the demands involved 
in keeping track of 18 adolescents’ progress and in managing such a 
caseload. The groups should start on a staggered basis, rather than 
simultaneously.  
In this way, the initial, heavy demand on clinicians’ time to see each 
participant for two individual sessions will be spread out. 
 
Staffing Recommendations 
 
In the first 2 weeks of the treatment, the therapist sees each participant 
for two individual therapy sessions. Over the following 3 weeks, the 
therapist conducts one group therapy session per week. Additional 
clinician time may be needed to handle emergencies that may occur, to 
address pragmatic issues such as scheduling and communication, or to 
make referrals. 
Additional staff is needed to conduct and score the initial assessments 
and prepare the personalized feedback reports. During a group therapy 
session, another staff person should be available in reasonable proximity 
to the group therapy room. This staff person (who may be doing other 
work) could assist in dealing with emergencies or supervising a client 
who has been asked to leave a group session because he or she is under 
the influence of drugs or exhibiting disruptive behavior. Details of the 
training which should be provided are included in Appendix 1. 
 
Supervision and Monitoring Procedures 
 
The therapists should receive 1 hour of supervision each week. Prior to 
certification, this supervision should be on an individual basis. All 
therapy sessions should be audio-taped or videotaped (with the consent 
of the adolescent participant and his or her parent/legal guardian). All 
therapists will need to demonstrate their competence in delivering 
MET/CBT5. The person providing the ongoing supervision may have 
participated as a trainer in the initial training of therapists; however, this 
in not necessary. It is crucial, however, that the clinical supervisor 
attends the training. The clinical supervisor should have at least 2 years’ 
experience in delivering and supervising motivational enhancement and 
cognitive behavioral therapies for substance abusers and in treating 
adolescents. Experience in supervising manual-based therapies is 
desirable. If the supervisor has not had experience supervising manual-
based therapies, it is recommended that he or she be provided with some 
related consultation and instruction. (See Appendix 2 for further detail 
on supervision). 
 
 Sequence of MET/CBT5 Treatment 
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While the first two sessions proceed primarily from a motivational 
enhancement therapy plan, and the remaining three sessions focus 
primarily on cognitive-behavioral interventions, it is expected that there 
will be some overlap of each of these approaches in all five sessions. For 
example, it is expected that therapists will make effective use of MET 
interventions, to some extent, across all five treatment sessions. (See 
Appendix 3 for more details of the content of sessions). 
 
8.4 What is the rationale for Group Therapy for problem cannabis 
use? 
 
Many of the problems or skill deficits associated with substance abuse 
are interpersonal in nature, and the context of a group provides a 
realistic yet “safe” setting for the acquisition or refinement of new skills. 
A number of features associated with group approaches to treatment 
may facilitate cognitive, affective, and behavioral changes. These factors 
include the realisation that others share similar problems; the 
development of adaptive social behaviors; the opportunity to try out new 
behaviours in a safe environment; and development and enhancement of 
interpersonal learning and trust. Group therapy breaks through 
individual's isolation, encouraging development of interdependence and 
identification with other cannabis users, while at the same time avoiding 
overdependence on the therapist. It also provides the therapist with an 
opportunity to observe the interpersonal behaviour of each group 
member. 
With respect to social skills training, important aspects of the treatment, 
particularly modeling, rehearsal, and feedback, probably occur more 
powerfully in a group than an individual 1:1 setting.  
A group-therapy format also provides opportunities for behavioural 
rehearsal and risk taking. Clients benefit from feedback offered by their 
peers, from discussions of anticipated obstacles to implementation of 
new skills, and from the case examples provided by fellow clients.  
Group therapy is the most widely used form of treatment delivery for 
substance abuse rehabilitation and has a high level of clinical relevance. 
Group therapy is relatively inexpensive because of its relatively high 
client-to-staff ratio. 
It can be a particularly powerful modality for teenage clients given the 
importance of peer influence in adolescence (Nowinski, 1990). Feedback 
from a peer is likely to have greater impact on adolescents than similar 
feedback from the therapist.  
In the group CBT sessions, therapists encourage participants to offer 
other group members positive and constructive feedback. At the same 
time, clients are equally susceptible to the negative influence of peers. As 
a result, it is especially important that the therapist monitor and address 
any antisocial comments and behaviors that occur in group sessions. 
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A randomized controlled trial of brief cognitive–behavioral interventions 
for cannabis use disorder was carried out in Australia to address this 
issue (Copeland et al, 2001).   A total of 229 participants were assessed 
and randomly assigned to a six-session CBT program (6CBT), a single-
session CBT intervention (1CBT), or a delayed-treatment control (DTC) 
group. Participants were assisted in acquiring skills to promote cannabis 
cessation and maintenance of abstinence and were followed-up.   
Follow up was at a median of 237 days after last attendance. Participants 
in the treatment groups reported better treatment outcomes than the 
DTC group. They were more likely to report abstinence, were significantly 
less concerned about their control over cannabis use, and reported 
significantly fewer cannabis-related problems than those in the DTC 
group. Those in the 6CBT group also reported more significantly reduced 
levels of cannabis consumption than the DTC group. While the therapist 
variable had no effect on any outcome, a secondary analysis of the 6CBT 
and 1CBT groups showed that treatment compliance was significantly 
associated with decreased dependence and cannabis-related problems.  
These findings support the efficacy of CBT interventions for cannabis use 
disorders and speak to the need for larger, multi-site replication studies 
to address the question of generalisability and the problem of low 
statistical power 
 
8.5 Manualised treatment 
 
Manuals were designed (see Sampl & Kadden (2000); Webb et al, (2002) 
Hamilton et al (2001); Godley et al (2001); Liddle (2002)) to help train 
substance abuse treatment counselors to conduct a brief five-session 
treatment intervention for adolescents with cannabis use disorders 
presenting for outpatient treatment. It combines two sessions of 
motivational enhancement therapy provided individually and three 
sessions of cognitive behavioral therapy provided in a group format. 
 
8.6 Integrated Treatment for Dual Disorders 
 
Adults with substance abuse disorders and mental illness (i.e. those with 
a dual diagnosis) require a comprehensive set of approaches, including 
assessment, individual, group and family work that can be tailored to the 
specific needs of individual programmes.  Mueser et al, (2003) 
summarise available knowledge on various treatment programs that have 
been researched in the dual diagnosis field separately and make 
recommendations on available individual interventions.   
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9. Conclusions  
 
Cannabis is the most widely used illegal drug in western societies. Users 
of cannabis have tended to view it as quite a benign drug. There is 
growing evidence that cannabis is addictive, contrary to popular opinion. 
There is also growing evidence regarding the long term changes in brain 
functioning which cannabis can induce. 
 
Unfortunately rates of cannabis use by young people in Ireland are high 
by European standards. Over one third of Irish schoolchildren have tried 
cannabis by the age of sixteen years. Nine per cent of Irish sixteen-year-
olds use cannabis at least three times per month. While rates of use have 
historically been higher in boys, rates of use demonstrated by girls are 
now equal to those seen in teenage boys. Rates of cannabis use are lower 
in older age groups. Students attending third level education report 
relatively high rates of use compared to other groups. Most people access 
cannabis from friends and use in social situations with peers. About one 
in ten current cannabis users are dependent upon the drug. This 
suggests that there are about 28000 Irish people are currently cannabis 
dependent. There is a need for further research to examine this sub-
group of heavy cannabis users in order to improve our understanding of 
the routes into and out of cannabis dependence. 
 
Cannabis users are a heterogeneous group. A variety of individual, family 
and social risk factors are associated with increased risk of cannabis 
abuse. Peer and family attitudes to intoxication in general and cannabis 
use in particular are predictive of cannabis abuse by individuals. 
 
Internationally, there has been substantial debate regarding the 
appropriate legislative and regulatory response to cannabis users. In the 
UK, cannabis was recently recategorised as a class C substance, having 
previously been a class B substance. In essence, this still means that 
cannabis use remains illegal, but use of a class C substance does not 
bring with it a criminal conviction. Surveys of Irish people indicate that 
the majority of Irish people do not want cannabis legalised. A substantial 
minority of past and current cannabis users do not wish to see cannabis 
legalised. Despite the existence of quite liberal laws on cannabis in the 
Netherlands, Irish teenagers demonstrate higher rates of cannabis 
experimentation than their Dutch counterparts. Although ‘coffee shops’ 
are permitted to sell cannabis in the Netherlands, it is estimated that 
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about two-thirds of the cannabis continues to be sold via criminal 
networks. 
 
There is now compelling evidence that cannabis abuse can result in later 
development of psychotic illness. Prolonged exposure to cannabis can 
induce changes to neurotransmitter pathways in vulnerable people. It 
seems that these changes can result in serious illness such as 
schizophrenia in some and result in cognitive impairment in others. 
Unfortunately, we cannot currently predict which cannabis users will 
develop these difficulties and who will not. In recent years it has also 
become clear that the human brain continues to develop during 
adolescence. It appears that cannabis use during this developmental 
phase, when brain architecture relating to some higher functions is being 
fine tuned, is most likely to result in long term impairment. It is 
important that education regarding these emerging risks of cannabis use 
is communicated in a balanced manner. For example, while teenagers 
engaging in heavy cannabis use have a two- to four-fold increase in risk 
of later development of schizophrenia, the vast majority of such 
teenagers will not develop this disorder. While scare tactics have been 
popular in past public information campaigns on drug misuse, they are 
counter-productive. 
 
There is also a need to support further neurobiological research to 
examine the long term cognitive impairment effects associated with heavy 
cannabis use, particularly those impairments relating to heavy use in 
adolescence and to prenatal exposure to cannabis. 
 
Cannabis users encounter the same profile of serious respiratory disease 
as that seen in cigarette smokers. This includes an elevated risk of 
chronic obstructive pulmonary disease and lung cancer. Women who 
smoke cannabis during pregnancy tend to have smaller babies. There is 
emerging evidence that exposure of the foetus to cannabis during 
pregnancy can result in brain changes and can result in detectable 
cognitive impairment during childhood. As young women increase in 
their use of cannabis in Ireland, there is need for greater public health 
awareness of these risks. 
 
Cannabis use contributes to a range of social harms in Ireland. After 
alcohol, it is the drug most frequently implicated in intoxication related 
road traffic accidents. Although cannabis does not generally cause users 
to become violent while intoxicated and contributes minimally to public 
order offences in Ireland, the illegal supply network involves violence and 
intimidation. It is estimated that the cannabis generates at least 375 
million euro for criminals in Ireland each year. However, a heavy 
cannabis smoker can maintain their habit on about 70 euro per week. 
Just over six thousand prosecutions relating to cannabis were initiated 
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in 2005. This necessitates substantial use of garda and court resources. 
There is dispute regarding the relative importance of the deterrent effect 
of the criminal status of cannabis on its use. The physical, psychological 
and social adverse consequences of cannabis use probably have a greater 
deterrent effect on cannabis use in the population at large. 
 
Young people in modern Ireland report easy access to cannabis and 
appear to have a broader menu of intoxicants than previous generations. 
The most widely abused substance in Ireland is alcohol. Binge drinking 
and drunkenness are highly tolerated across the age ranges in Ireland by 
international standards. This widespread drunkenness provides effective 
camouflage for people who chose to get intoxicated via other substances.  
 
Despite higher prevalence of cannabis use in the greater Dublin area, 
rates of attendance for cannabis treatment are very low in Dublin 
compared to elsewhere in Ireland. While addiction treatment services in 
Dublin have provided a comprehensive response to heroin abuse, there is 
now a need for development of a treatment response for other 
substances, including cannabis. There is growing evidence regarding 
effective treatment approaches for cannabis dependence. Treatment 
should be delivered by professional staff skilled in the evidence based 
treatment approaches. The vast majority of people who are cannabis 
dependent can be treated on an outpatient basis. There is growing 
evidence regarding the neurobiology of addiction. There are high rates of 
comorbidity between cannabis dependence and other mental health 
disorders. Mental health professionals have all of the core skills required 
to deliver high quality addiction treatment. Consequently, we believe that 
addiction treatment services should be intergarted within a mental 
health services framework.  
 
The Irish Government has never instituted a sustained public health 
education campaign on the health effects of cannabis.  We need 
Government to recognise that cannabis is primarily a health issue, not a 
legal issue and to deal with it accordingly. Education regarding cannabis 
is required across society and should not be exclusively focused on 
teenagers or schools. Indeed, teenagers are probably better informed 
about the risks and consequences of cannabis use than are their parents 
(see Appendix 4). 
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Appendix 1.  
 
The recommended Training required  by therapists providing Five sessions 
MET/CBT5. 
 
The training should be provided by a graduate-level clinician (or a team 
of clinicians) experienced (minimum of 2 years) in providing, supervising, 
and training motivational enhancement and cognitive behavioral therapy 
for substance abusers. The trainer should also have at least 2 years of 
clinical experience with adolescents. The trainer should have extensive 
knowledge of the treatment manual contents. The training should 
include a variety of formats including the following: 
• Instruction of rationale and procedures 
• Observation of live and/or videotaped examples 
• Active practice exercises with feedback. 
By varying the formats and by including engaging visual aids, the trainer 
will be more likely to keep participants actively involved. To increase 
engagement and clarity, the trainer should welcome and encourage 
participants’ questions and comments. 
If MET/CBT5 therapy is to be used in a multi-site clinical research 
project, or in a multi-site agency where the intent is consistent delivery 
and enhanced cohesiveness, it is recommended that the initial training 
be centralized to one common site and session. This way the therapists 
at each site will have a common foundation from which to work. During 
the centralized training, they will have a chance to hear the comments 
and questions of therapists at other sites and thus will be exposed to a 
wider range of issues that may come up in applying the intervention. 
Another likely benefit of centralized training is the potential for it to 
generate cohesiveness and enthusiasm, whereby participating therapists 
get the feeling of being a part of the big picture. The trainer can help with 
this by making enthusiastic comments about being included among 
therapists who will implement this new therapy, as well as by 
encouraging participants to interact with those from other sites during 
practice exercises and breaks. 
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Appendix 2 
 
Supervision and Monitoring Procedures recommended for therapist 
providing MET/CBT5. 
 
The person providing the ongoing supervision may have participated as a 
trainer in the initial training of therapists; however, this in not 
necessary. 
It is crucial, however, that the clinical supervisor attends the training. 
The clinical supervisor should have at least 2 years’ experience in 
delivering and supervising motivational enhancement and cognitive 
behavioral therapies for substance abusers and in treating adolescents. 
Experience in supervising manual-based therapies is desirable. If the 
supervisor has not had experience supervising manual-based therapies, 
it is recommended that he or she be provided with some related 
consultation and instruction. 
The therapists should receive 1 hour of supervision each week. Prior 
to certification, this supervision should be on an individual basis. All 
therapy sessions should be audio-taped or videotaped (with the consent 
of the adolescent participant and his or her parent/legal guardian). All 
therapists will need to demonstrate their competence in delivering 
MET/CBT5.  
The two initial individual MET sessions are primarily intended to 
enhance adolescents’ motivation to address their marijuana use and to 
prepare the clients for the group sessions, with an introduction to 
functional analysis and the concept of triggers. The purpose of the three 
group sessions is to assist clients in the development of skills useful for 
stopping or reducing marijuana use. The CBT sessions focus on the 
following skills: 
• Learning basic skills for refusing offers of marijuana 
• Developing a plan for pleasant drug-free activities 
• Establishing a social network that will support recovery 
• Coping with high-risk situations 
• Recovering from a relapse, should one occur. 
The table below illustrates the sequence of the five sessions of the 
MET/CBT5 treatment. Note that the first two (individual) sessions are 
expected to last for 60 minutes. The final three (group) sessions are 
scheduled to run for 75 minutes. 
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Appendix 3 
 
Content of Sessions MET/CBT5.  
  
Sequence of MET/CBT5 Treatment 
Session Modality Time Primary Topics 
Period Approach 
x Session 1: Individual 60 min.  
MET Rapport and motivation building. 
Review of personalized feedback report. 
 
x Session 2: Individual 60 min.  
MET Goal setting. 
Introduction to functional analysis. 
Preparation for group sessions. 
 
x Session 3: Group 75 min.  
CBT Marijuana refusal skills, with role play practice exercises. 
 
x Session 4: Group 75 min.  
CBT Enhancing social support network 
Increasing pleasant activities.  
 
x   Session 5: Group 75 min.  
CBT Coping with unanticipated high-risk situations and relapses. 
While the first two sessions proceed primarily from a motivational 
enhancement therapy plan, and the remaining three sessions focus 
primarily on cognitive-behavioral interventions, it is expected that 
there will be some overlap of each of these approaches in all five 
sessions. For example, it is expected that therapists will make 
effective use of MET interventions, to some extent, across all five 
treatment sessions. 
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Appendix 4  
 
Prevention by raising awareness about Cannabis 
 
Given the lack of awareness of parents and professional, an awareness 
campaign similar to that described by the Psychological Society of Ireland 
Presidential Advisory Group on the Public Understanding of Psychology 
(PAGOTPUP), may prove effective, (Hughes, B., Adelaja, Y., Carroll-
Phelan, B., et al 2005).  
 
Their list of strategies to increase awareness included: 
 
Websites: 
 
Given the openness of Ireland to international cultural influences, many 
Irish residents’ perceptions of the role of psychologists are shaped more 
by professional realities in countries such as the US and the UK than 
they are by the profession here. For example, in a society where many 
people’s primary source of information on psychological matters is either 
the Internet or imported television shows. 
 
Secondly, it appears to be the case that there is a gap in that parents 
leave education about cannabis to professionals and professionals leave 
awareness about cannabis to parents. This research does not distinguish 
among professional specialisms (e.g., clinical psychology, counseling 
psychology, educational psychology, health psychology, teachers or 
General practitioners).  
 
The general public 
 
Notwithstanding the wisdom of targeting specialised audiences, it is 
clearly important to seek to address a global public audience with 
initiatives that enhance their understanding of the difficulties associated 
with cannabis use. 
 
Allied pressure groups 
 
Some members of the general public are involved in (or else are 
particularly sensitive to) single-issue pressure groups and campaigns. 
Members of the public concerned about psychological issues such as 
suicide, addictions, special educational needs, bullying, and so on, will 
be especially motivated to receive information on psychology and 
psychologists, and so generically designed public understanding 
interventions may be sub-optimally focused for such audiences. 
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Allied professionals 
 
Experience suggests that allied professionals are often quite amenable to 
psychology as a profession or discipline, but that their receptiveness to it 
is tempered by a lack of understanding across most of the areas 
identified above. Given that allied professionals have existing network 
contacts with psychologists, successful initiatives to improve 
understanding ought to capitalise on these relationships. It should be 
noted that although important in relation to psychology in the health 
services, the targeting of initiatives to allied professionals should not be 
exclusive to health settings. Educational psychologists, organisational 
psychologists, and academic psychologists also occupy work settings 
that are characterised by a high degree of interaction with other 
professionals. 
 
Government departments and state agencies 
 
As psychologists working for the state can testify, it would be a mistake 
to assume that organisations of state which are ultimately responsible 
for overseeing psychology training, service availability, or funding 
(including research funding) are sophisticated in their understanding of 
what psychological difficulties and interventions involves. However, given 
the oversight roles they occupy, initiatives to improve their 
understanding should be designed specifically with their organisational 
perspective in mind. 
 
The media 
 
The media will inevitably be involved, directly and indirectly, in a good 
deal of the understanding and misunderstanding of substance misuse 
including cannabis. Experience suggests that there is substantial scope 
for improvement in the way in which the media reports on cannabis use 
and its effects. The media as a profession are continuously receptive to 
briefings and appear ever keen to enhance their understanding of the 
specialist areas on which they report. 
 
School students 
 
There are at least two reasons why school students represent a separate 
sub audience to which particular initiatives should be directed. Firstly, 
school students are the main source of concern in relation to cannabis 
use, and their approval or disapproval influences cannabis use. 
Secondly, school children can represent a vehicle for the promotion of the 
understanding of the difficulties associated with cannabis use among the 
wider public, by being an easily accessed group with immediate links via 
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parents and families to the community at large. There is also a sense in 
which it can be seen as valuable to inform members of the public about 
the risks associated with cannabis misuse while they are still young, 
prior to their exposure to the extensive misinformation that appears to 
circulate widely about “the weed”. 
 
Psychologists 
 
Psychologists represent a perhaps unexpected target audience for efforts 
to promote the public understanding of the risks associated with 
cannabis use. However, there are three contexts in which attention may 
be directed at psychologists themselves. 
x Firstly, undoubtedly some psychologists fall foul of some of 
the misconceptions about the risks associated with 
cannabis use. 
x Secondly, in the era of Continuing Professional 
Development, it is incumbent on professional bodies to 
keep (or help to keep) their members abreast of emerging 
developments in the emerging research on cannabis so 
that their understanding of it is maintained at a 
sophisticated level.  
x And thirdly, it would appear that many psychologists seem 
to underestimate the extent of cannabis use, and the 
potential damaging effects, of the public’s current 
misunderstanding of the risks associated with cannabis 
use. 
Part of the endeavour to enhance public understanding will be to inform 
psychologists themselves of the pertinent issues concerning public 
understanding, and to involve them in awareness-raising as 
ambassadors for their discipline. 
 
 
Modalities of understanding-enhancement efforts 
 
The variety of misconception and target audience suggests that a number 
of different ways of improving public understanding of cannabis use and 
the risks associated therewith can be considered.  
 
Leaflets and pamphlets 
 
By far the most commonly suggested format for understanding-
enhancement efforts was the production of appropriate leaflets, 
pamphlets, or fact-sheets. It seems true that such leaflets remain 
extremely common despite the potentially elaborate alternatives offered 
by our multimedia technological age. For example, many of our sister 
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professions invest much energy (and finances) in the production of 
information leaflets, presumably having considered various other 
options. The prevalence of leaflets (as would be evidenced by the vast 
number of leaflets relating to professional services and health concerns 
available in the public waiting areas of health-care institutions) would 
imply that members of the public would be very familiar with such a 
format 
 
The notion of a “pamphlet” may represent something more substantial 
than a leaflet. Such a product may be used to represent some of the 
detail required to reach particular target audiences with relevant 
information. For example, the enhancement of understanding of 
cannabis and its side effects among state agencies may not be adequately 
addressed through a simple leaflet. 
 
Web-based information 
 
Where leaflets are produced, it is necessary in the modern era to make 
such materials available online. This could mean that all leaflets should 
be downloadable from a website. A thorough and comprehensive 
information store, easily navigable and referenced to a Frequently Asked 
Questions section, would appear to be a basic minimum requirement for 
a modern society concerned about cannabis use. Compared to paper-
based media, the associated financial costs and problems with in-built 
obsolescence are minimal. 
It is likely that members of the public who are motivated to proactively 
seek out information on cannabis would access such a site. However, the 
availability of online resources will not completely achieve the objective of 
enhancing public understanding on its own. 
 
Public lectures 
 
The holding of public lectures on cannabis use offers a relatively low-cost 
but potentially fruitful way of addressing a number of target audiences, 
especially those who may not be reached via electronic or paper 
modalities.  A series of public lectures around the country may be 
helpful. 
 
Exhibitions 
 
The notion of an exhibition, of exhibition stands, or of an “open day”-type 
event could be invoked to access particular target audiences such as 
school students or other professions e.g. an exhibition or information-
stand at the annual conferences of professional bodies. 
As regards reaching the general public, there would appear to be several 
opportunities for education re cannabis to be represented at larger scale 
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events run by other organisations. For example, such events might 
include the Young Scientists Exhibition or the Irish Times Higher Options 
Conference (the annual exhibition, held in Dublin, aimed at helping 
school-leavers choose courses at third level). As well as reaching 
delegates, it is notable that these events attract a considerable degree of 
media coverage. The fact that such exhibitions are well-established 
national events should offset the cost. 
It can be noted that during its centenary year, the British Psychological 
Society organised a number of such events across the UK, involving 
major arts bodies and institutions (e.g., art exhibitions at major 
galleries). The relationship between mental health and artistic work is 
very ingrained in the public imagination, and so it is possible to conceive 
of such events being organised around a wide range of arts and media.  
 
Press Officer 
  
The appointment of a Press Officer may be fruitful in addressing the 
understanding of cannabis through the media. 
 
Press articles and other media contributions 
 
A concerted effort could be made to secure regular columns or sections 
on cannabis in the national media. Most national newspapers produce 
weekly or monthly health and education supplements, which frequently 
carry articles on substance abuse themes. Similarly, most also run 
regular sections on science.  
Specialist industry periodicals, such as magazines whose circulation is 
restricted to a given profession (e.g. The Medical Times), or similarly 
specialised websites (e.g., irishhealth.com) may also be approached in a 
similar manner. 
Finally, a similar effort could be made to apprise other media (e.g. TV 
and radio) of the availability of contributors with an interest in psycho-
education re cannabis.  
 
Media guidelines 
 
As well as liaising personally with the media on specific issues, it may be 
useful to issue reporting guidelines on cannabis use and the 
consequences of such use. 
 
 
Posters 
Some well designed and modern posters aimed at raising awareness 
about the effects of cannabis use similar to those used in Australia and 
America. 
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Conclusion 
 
It is probably the case that public misunderstanding of the safety of 
cannabis use can never be fully addressed, and that the promotion of 
public understanding will be a permanent function of any group 
attempting to raise awareness.  
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An Comhchoiste um 
Ghnóthaí Ealaíon, 
Spóirt, Turasóireachta, 
Pobail, Tuaithe agus 
Gaeltachta 
Teach Laighean 
Baile Átha Cliath 2 
 
 
 
Joint Committee on Arts, Sport, 
Tourism, Community, Rural and 
Gaeltacht Affairs 
Leinster House 
Dublin 2 
 (01) 618 3000 
Fax (01) 618 4123 / 618 4124 
 
 
 
Members of the Joint Committee 
 
Deputies: 
 
Martin Brady (FF)  
James Breen (Ind) 
Michael Collins (Ind) 
Jimmy Deenihan (FG) 
Jim Glennon (FF) [Vice-Chairman] 
Cecilia Keaveney (FF) [Chairman] 
Peter Kelly (FF) 
Dinny McGinley (FG) 
Brian O’Shea (Lab) 
Jack Wall (Lab) 
G.V. Wright (FF) 
 
 
Senators: 
 
Brendan Daly (FF) 
Frank Feighan (FG) 
Joe McHugh (FG) 
Labhrás Ó Murchú (FF) 
Joe O’Toole (Ind) 
Kieran Phelan (FF) 
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Orders of Reference of the Joint Committee 
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Orders of Reference 
 
Dáil Éireann on 16 October 2002 ordered: 
 
“(1) (a) That a Select Committee, which shall be called the Select Committee on 
Arts, Sport, Tourism, Community, Rural and Gaeltacht Affairs, consisting 
of 11 members of Dáil Éireann (of whom 4 shall constitute a quorum), be 
appointed to consider  - 
 
(i) such Bills the statute law in respect of which is dealt with by the 
Department of Arts, Sport and Tourism and the Department of 
Community, Rural and Gaeltacht Affairs;  
 
(ii) such Estimates for Public Services within the aegis of the 
Department of Arts, Sport and Tourism and the Department of 
Community, Rural and Gaeltacht Affairs; and 
 
                        (iii) such proposals contained in any motion, including any motion 
within the meaning of Standing Order 157 concerning the approval 
by the Dáil of international agreements involving a charge on 
public funds,  
 
as shall be referred to it by Dáil Éireann from time to time. 
 
(b) For the purpose of its consideration of Bills and proposals under 
paragraphs (1)(a)(i) and (iii), the Select Committee shall have the powers 
defined in Standing Order 81(1), (2) and (3). 
  
(c) For the avoidance of doubt, by virtue of his or her ex officio membership 
of the Select Committee in accordance with Standing Order 90(1), the 
Minister for Arts, Sport and Tourism and the Minister for Community, 
Rural and Gaeltacht Affairs (or a Minister or Minister of State nominated 
in his or her stead) shall be entitled to vote. 
 
(2)      (a) The Select Committee shall be joined with a Select Committee to be 
appointed by Seanad Éireann to form the Joint Committee on Arts, Sport, 
Tourism, Community, Rural and Gaeltacht Affairs to consider - 
 
(i) such public affairs administered by the Department of Arts, Sport 
and Tourism and the Department of Community, Rural and 
Gaeltacht Affairs as it may select, including, in respect of 
Government policy, bodies under the aegis of those Departments;  
     
(ii) such matters of policy for which the Minister for Arts, Sport and 
Tourism and the Minister for Community, Rural and Gaeltacht 
Affairs are officially responsible as it may select; 
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(iii) such related policy issues as it may select concerning bodies which 
are partly or wholly funded by the State or which are established or 
appointed by Members of the Government or by the Oireachtas; 
  
(iv) such Statutory Instruments made by the Minister for Arts, Sport 
and Tourism and the Minister for Community, Rural and Gaeltacht 
Affairs and laid before both Houses of the Oireachtas as it may 
select; 
 
(v) such proposals for EU legislation and related policy issues as may 
be referred to it from time to time,  in accordance with Standing 
Order 81(4); 
 
(vi) the strategy statement laid before each House of the Oireachtas by 
the Minister for Arts, Sport and Tourism and the Minister for 
Community, Rural and Gaeltacht Affairs pursuant to section 5(2) 
of the Public Service Management Act, 1997, and the Joint 
Committee shall be so authorised for the purposes of section 10 of 
that Act; 
 
                       (vii) such annual reports or annual reports and accounts, required by 
law and laid before either or both Houses of the Oireachtas, of 
bodies specified in paragraphs 2(a)(i) and (iii), and the overall 
operational results, statements of strategy and corporate plans of 
these bodies, as it may select; 
 
 Provided that the Joint Committee shall not, at any time, 
consider any matter relating to such a body which is, which has 
been, or which is, at that time, proposed to be considered by the 
Committee of Public Accounts pursuant to the Orders of Reference 
of that Committee and/or the Comptroller and Auditor General 
(Amendment) Act, 1993; 
 
Provided further that the Joint Committee shall refrain from 
inquiring into in public session, or publishing confidential 
information regarding, any such matter if so requested either by the 
body or by the Minister for Arts, Sport and Tourism and the 
Minister for Community, Rural and Gaeltacht Affairs; and 
 
(viii) such other matters as may be jointly referred to it from time to time 
by both Houses of the Oireachtas,  
 
and shall report thereon to both Houses of the Oireachtas.   
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 (b)  The quorum of the Joint Committee shall be five, of whom at least one 
shall be a member of Dáil Éireann and one a member of Seanad Éireann. 
 
(c) The Joint Committee shall have the powers defined in Standing Order 
81(1) to (9) inclusive. 
 
(3) The Chairman of the Joint Committee, who shall be a member of Dáil Éireann, 
shall also be Chairman of the Select Committee.”. 
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Seanad Éireann on 17 October 2002 (*23 October 2002) ordered: 
 
(1)  (a) That a Select Committee consisting of 6 members* of Seanad Éireann 
shall be appointed to be joined with a Select Committee of Dáil Éireann to 
form the Joint Committee on Arts, Sport, Tourism, Community, Rural and 
Gaeltacht Affairs to consider- 
 
(i) such public affairs administered by the Department of Arts, Sport 
and Tourism and the Department of Community, Rural and 
Gaeltacht Affairs as it may select, including, in respect of 
Government policy, bodies under the aegis of those Departments; 
 
(ii) such matters of policy for which the Minister for Arts, Sport and 
Tourism and the Minister for Community, Rural and Gaeltacht 
Affairs are officially responsible as it may select; 
 
(iii) such related policy issues as it may select concerning bodies which 
are partly or wholly funded by the State or which are established or 
appointed by Members of the Government or by the Oireachtas; 
 
(iv) such Statutory Instruments made by the Minister for Arts, Sport 
and Tourism and the Minister for Community, Rural and Gaeltacht 
Affairs and laid before Houses of the Oireachtas as it may select; 
 
(v) such proposals for EU legislation and related policy issues as may 
be referred to it from time to time, in accordance with Standing 
Order 65(4); 
 
(vi) the strategy statement laid before each House of the Oireachtas by 
the Minister for Arts, Sport and Tourism and the Minister for 
Community, Rural and Gaeltacht Affairs pursuant to section 5(2) 
of the Public Service Management Act, 1997, and the Joint 
Committee shall be so authorised for the purposes of section 10 of 
that Act; 
 
                        (vii) such annual reports or annual reports and accounts, required by 
law and laid before both Houses of the Oireachtas, of bodies 
specified in paragraphs 1(a)(i) and (iii), and the overall operational 
results, statements of strategy and corporate plans of these bodies, 
as it may select; 
 
                                                 
* by the substitution of ‘6 members’ for ‘4 members’. 
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Provided that the Joint Committee shall not, at any time, 
consider any matter relating to such a body which is, which has 
been, or which is, at that time, proposed to be considered by the 
Committee of Public Accounts pursuant to the Orders of Reference 
of that Committee and/or the Comptroller and Auditor General 
(Amendment) Act, 1993; 
 
Provided further that the Joint Committee shall refrain from 
inquiring into in public session, or publishing confidential 
information regarding, any such matter if so requested either by the 
body concerned or by the Minister for Arts, Sport and Tourism or 
the Minister for Community, Rural and Gaeltacht Affairs;  
 
and 
 
(viii) such other matters as may be jointly referred to it from time to time 
by both Houses of the Oireachtas,  
 
and shall report thereon to both Houses of the Oireachtas.  
 
(b)  The quorum of the Joint Committee shall be five, of whom at least one 
shall be a member of Dáil Éireann and one a member of Seanad Éireann. 
 
(c) The Joint Committee shall have the powers defined in Standing Order 
65(1) to (9) inclusive. 
 
(2)   The Chairman of the Joint Committee shall be a member of Dáil Éireann. 
 
 
 
 
 
 
 
 
 
 
